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Occurrence of Escherichia coli non-susceptible to quinolones in fecal and 
environmental samples from pigs at different ages after fluoroquinolone treatment 
in piglets or their dams 
Abstract 
 
Despite their indispensability in human medicine fluoroquinolones (FQ) are used in 
farm animals which inherits the risk of transferring FQ resistant bacteria into the 
environment and via food chain to human beings. More research is needed in 
revealing possible transfer mechanisms and factors promoting antibiotic resistance 
in bacteria. The objectives of this study were to do a follow-up of the presence of 
quinolone non-susceptible Escherichia coli (QNSE) qualitatively and quantitatively 
in fecal and environmental samples of pigs at four time points and with various FQ 
backgrounds. 40.9% (95% CI: 37.0-44.9%) of fecal and 14.0% (95% CI: 9.4-
19.7%) of environmental samples contained QNSE. Detection rates of QNSE in 
treated and contact pigs did not differ significantly and were highest in piglets of 
two- and four-weeks of age. However, the detection rates and counts of QNSE in 
control pigs were significantly lower compared to treated and contact pigs. 49.6% 
and 40.0% of isolates in fecal and environmental samples were intermediate or 
resistant to ciprofloxacin (≥ 3 µg/ml ciprofloxacin), respectively. QNSE were 
present in the pig’s environment and in pigs independent of age or FQ 
background. New approaches are needed to minimize the emergence and transfer 
of FQ resistant bacteria from treated pigs to other pigs and the environment. 
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Auftreten von Chinolon-intermediär und -resistenten Escherichia coli im Kot von 
Schweinen unterschiedlichen Alters und in Umgebungsproben nach 
Fluorchinolonbehandlung der Saugferkel oder deren Muttersau 
Zusammenfassung 
 
Trotz ihrer Unentbehrlichkeit in der Humanmedizin und dem Risiko einer 
Übertragung von Fluorchinolon-resistenten Bakterien in die Umwelt und via 
Nahrungskette zu den Menschen sind Fluorchinolone bei Nutztieren weiterhin im 
Einsatz. Weitere Erkenntnisse zu Übertragungsmechanismen und 
Antibiotikaresistenzen-fördernden Faktoren sind nötig. In dieser Studie wurden 
Chinolon-unempfindliche Escherichia coli (QNSE) qualitativ und quantitativ in Kot- 
und Umgebungsproben von Schweinen mit unterschiedlicher Fluorchinolon-
Vorgeschichte an vier verschiedenen Alterszeitpunkten bestimmt. 40.9 % (95% CI: 
37.0-44.9 %) aller Kot- und 14.0 % (95% CI: 9.4-19.7 %) aller Umgebungsproben 
enthielten QNSE. In zwei- und vierwöchigen Ferkeln waren die Detektionsraten 
von QNSE am höchsten. In behandelten und Kontaktschweinen unterschied sie 
sich nicht signifikant. Hingegen waren die Detektionsraten und die Mengen an 
QNSE in Kontrollschweinen signifikant tiefer verglichen mit behandelten und 
Kontaktschweinen. 49.6 % und 40.0 % aller E. coli-Isolate von Kot- und 
Umgebungsproben waren intermediär oder resistent gegenüber Ciprofloxacin (≥ 3 
µg/ml Ciprofloxacin). Unabhängig des Alters und der Fluorchinolon-Vorgeschichte 
der Schweine waren QNSE im Kot von und in der Umgebung der Schweine 
nachweisbar. Neue Bekämpfungskonzepte sind erforderlich um das Auftreten und 
die Übertragung von Fluorchinolon-resistenten Bakterien von behandelten 
Schweinen auf andere Schweine und deren Umgebung zu minimieren. 
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Quinolones, e.g. nalidixic acid, are synthetic antimicrobial agents introduced for 
the first time in 1963. Chemical modifications enabled fluoroquinolones (FQ) to 
work against a wide spectrum of bacteria, including Enterobacteriaceae, gram 
positive bacteria and anaerobes, in many different body tissues. The main 
mechanism of action is to block DNA supercoiling and replication by inhibiting 
catalyzing topoisomerases which inevitably leads to death of the bacterial cell. The 
topoisomerase II of Escherichia coli (E. coli) is built of the subunits GyrA and 
GyrB. Mutations in the quinolone resistance determining regions (QRDR) of gyrA 
and gyrB result in high-level quinolone and fluoroquinolone resistance [1, 2]. 
According to the classification published by the World Health Organization (WHO), 
FQ are part of the highest priority critically important antimicrobials (HPCIAs) due 
to their need in treating patients suffering from zoonotic diseases, e.g. 
salmonellosis and campylobacteriosis, or protecting neutropenic patients from 
septicemia [3, 4]. In Switzerland a national strategy against antibiotic resistances 
was established with Swiss FQ sales figures steadily declining [5, 6]. Restricted 
prescription and therapeutic guidelines for veterinarians shall promote a 
responsible and sustainable handling of antibiotics [7, 8]. In Europe, Canada and 
Japan detection rates of porcine pathogenic FQ resistant E. coli isolated from 
swine lie between 0% and 39% [9, 10]. This is in contrast to China and Brazil 
which are reporting very high resistance rates (81.0% and 54.4%) in porcine 
pathogenic and commensal E. coli from swine [11, 12]. Number of human beings 
infected with FQ resistant bacteria has increased since the introduction of FQ into 
veterinary medicine. An association between the prevalence in swine or poultry 
herds and the number of diseased patients was proved [13-17]. Slaughter process 
and kitchen hygiene are two crucial points in transfer of pathogenic bacteria [18, 
19]. Nevertheless, animal traffic, liquid manure spread onto croplands and dust of 
farms are other considerable transmission pathways in livestock and between 
animals and human beings [20-24]. FQ are mostly excreted unchanged by the 
body via urine and feces. Although they have a low bioavailability in soil, they form 
almost undegradable ion-complexes. FQ concentrations have been positively 
correlated with the abundance of plasmid mediated quinolone resistance genes in 
soil and wastewater and promote horizontal transfer of antimicrobial resistance 
genes [1, 25-28]. 
In pathogenic and commensal E. coli isolated from Swiss pigs (sows, weaners and 
fattening pigs) a low rate of ciprofloxacin resistance (< 2%) was reported [29, 30]. 
Current research about FQ resistance rates and transfer between FQ treated and 
not FQ treated pigs is contradictory comparing two German experimental studies. 
According to the first report in both groups (held in the same room) commensal E. 
coli with MIC ≥ 4 mg/ml enrofloxacin were detected [31]. However, during and 42 
days after FQ treatment no ciprofloxacin resistant E. coli (MIC ≥ 4 mg/ml 
enrofloxacin) were observed neither in the treated nor in the untreated contact 
groups or in the control group (held in a separate room) in a recently published 
study [32]. Depending on age, fattening pigs showed lower resistance rates 
compared to pigs of younger ages [33, 34]. To the authors’ knowledge, there has 
not been any individual, quantitative longitudinal study of quinolone non-
susceptible E. coli (QNSE) in pigs with different FQ background so far. Therefore, 
a field study was performed to monitor QNSE quantitatively in pigs either treated 
(intramuscularly, perorally or lactogenically via treated dam), in contact with 
treated pigs or dams and without any contact to treated or contact pigs (control). 
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Pigs and their environment were screened at four different time points (two-week 
old piglets, four-week old piglets, weaners and fattening pigs). Additionally, the 
isolates’ minimal inhibitory concentrations (MICs) of nalidixic acid and ciprofloxacin 




- Are there differences in detection rates of QNSE depending on group (G1 
to G5 or treated vs. contact vs. control) and the sampled age category? 
- Are the counts of QNSE in treated, untreated contact and control weaners 
and fattening pigs different? 
- Do susceptibility rates and minimal inhibitory concentrations (MICs) of 
nalidixic acid and ciprofloxacin differ between study groups and age 
categories? 
 
Secondary outcomes:  
 
- Are detection rates and counts of QNSE different between pigs of farms 
being part of a sow-pool-system (SPS) and pigs of farms not part of a SPS? 
- Depending on group category (G1 to G5 or treated vs. contact. vs. control) 
or the connection to a SPS do susceptibility proportions differ? 
- What are the detection rates and counts of QNSE in different materials 
(dust, slurry, pen wall and floor wipes) of the investigated pigs’ 
environment? 
- What are the susceptibility rates and MICs of nalidixic acid and ciprofloxacin 
in the pigs’ environment?  
 
 8 




Sampling was performed on 24 Swiss pig farms between May 2017 and May 
2018: three small to medium-sized farrow-to-finish farms (75 - 150 sows), two 
small farrowing farms (22 and 14 farrowing pens connected to a sow-pool-system 
with 1’200 sows), four small farrow and rearing farms (two farms with twelve and 
30 sows, two farms with 22 and 23 farrowing pens connected to a sow-pool-
system with 1’200 sows) one medium-sized rearing and finishing farm (400 
weaner and 480 fattening pigs) and 14 small to medium-sized fattening farms (40 - 
1’500 fattening pigs). Thirteen farms were part of a sow-pool-system (SPS): two 
farrowing farms, two farrow and rearing farms, one rearing and finishing farm and 
eight fattening farms. Inclusion criteria for study farms was a regular FQ usage 
restricted to either piglets or sows (in lactating sows: one farrow-to-finish farm, one 
farrow and rearing farm, two farrowing farms; in piglets: two farrow and rearing 
farms). Additionally, farms with no use of FQ in any age category for at least three 
to 34 months (two farrow-to-finish farms, one being part of a SPS, one farrow and 
rearing farm, one rearing and fattening farm and all 14 fattening farms) were 
included in order to compare the dissemination of quinolone non-susceptible E. 
coli. The main indications for FQ treatment in sows and piglets were either 
postpartum dysgalactia syndrome (PPDS) in sows or septic arthritis or diarrhea in 
piglets. Treatments were carried out by the farmers following their private 
veterinarian’s medical prescriptions including single and multiple FQ treatments 
(according to the drugs’ summary of products characteristics (SPC) parenteral in 
sows: Baytril®5% (enrofloxacin), 2.5 mg/kg SID; Marbocyl®10% (marbofloxacin), 2 
mg/kg SID, parenteral or oral in piglets: Marbocyl®2% (marbofloxacin), 2 mg/kg 
SID; Baytril®0.5% (enrofloxacin), 1.7 mg/kg SID). Two piglets received a second 
FQ treatment after weaning (Baytril®0.5% (enrofloxacin), 1.7 mg/kg SID) but the 
remaining sows and their progeny did not receive any additional FQ treatment 
during study conduction apart from the initial FQ treatment. Other reported 
antimicrobials used during the study were sulfadoxin-trimethoprim (parenteral in 
sows), amoxicillin, benzylpenicillin and in combination with streptomycin 
(parenteral in piglets), colistin, sulfadimidine-sulfathiazole-trimethoprim, 
chlortetracycline and chlortetracycline-sulfadimidin-tylosin (oral during weaning or 
fattening). Sampled pigs were divided into five groups. In two groups (G1 and G3, 
summarized as Trt) either the dams or the piglets were treated with 
fluoroquinolones (G1: sows FQ treated, piglets not FQ treated; G3: sows not FQ 
treated, piglets FQ treated). On every farm sampling of contact pigs was 
performed forming groups G2 and G4 (contact sows and piglets not FQ treated, 
summarized as Ctat). Contact pigs are summarised as pigs not treated with FQs 
but held in the same group with FQ treated pigs, i.e. having direct contact, or pigs 
not treated with FQs but held in the same room or farm, i.e. having indirect 
contact. Control pigs from farms without FQ use for more than three months 
belonged to the fifth group (G5 = Ctrl: sows and piglets from FQ free farms). 
Information on group formation and farm structure are summarized in Table 1. 
Study designers did not have any influence on the distribution of group animals 
from the farrowing to the fattening units. Thus, one fattening unit received pigs 








Farrowing farms were contacted after the sows’ expected delivery date. When FQ 
treatment was reported, farms were visited approximately two weeks after 
farrowing. Sampling was performed in two different steps in the farrowing units: In 
farms with FQ use in sows three piglets from every sow (treated or untreated) 
were randomly picked and a pooled fecal sample of approximately 1g to 5g was 
taken rectally or during defecation. This procedure was used to ensure sufficient 
sample material for the following laboratory procedures. In farms with FQ use in 
piglets we were able to collect single fecal samples of the same amount described 
above. Contact and treated piglets were picked from the same litter if piglets were 
suffering from septic arthritis. Since farmers performed metaphylaxis (treating all 
piglets) in litters suffering from diarrhea, a different litter was selected for control 
sampling. Gloves were changed after each sample to avoid cross-contamination. 
Untreated and treated sows or piglets were always held in the same room or farm 
and direct contact between litters and sows was possible through pen barring. A 
numbered ear tag of contrasting color in the left ear and the four-digit number of 
the Swiss animal movement data base in the right ear ensured group and 
individual identification for the following samplings. Because of a low prevalence of 
ciprofloxacin resistance in E. coli from Swiss pigs and a study recommending 
pooled samples only if prevalence of resistance is > 2% we preferred to collect 
single fecal samples in the following samplings to record the pigs’ individual 
courses [29, 30, 35]. Sampling was timed by the dates when pigs were moved to 
another facility to assess quinolone susceptibility status in every animal before and 
after movement: in the farrowing unit piglets were resampled at four weeks of age 
shortly before moving to the rearing unit. Subsequently, feces were collected at 
the end of rearing around ten weeks (weaners) and at least two weeks after 
moving to the fattening unit (fattening pigs at an age around twelve weeks). 
Because there had been no use of FQ for more than three months in the farrowing 
unit we forewent collecting piglet feces from group 5 (Figure 1). 
Due to subsequent processing collected native feces were individually kept in a 
stool tube and stored at - 20°C on the same day. 
All sampling procedures were approved by cantonal veterinary authorities (licence 



















G1 Trt S+P- + - 
1 2 (SPS) 1 (SPS) 1 (SPS) 7 (7 SPS) 
G2 Ctat S-P- - - 
G3 Trt S-P+ - +   
2 (1 SPS) 
 6 (5 SPS) 
G4 Ctat S-P- - -    5 (5 SPS) 
G5 Ctrl FQ free - - 2  1  3 (1 SPS) 
TOTAL      3 2 (SPS) 4 (2 SPS) 1 (SPS) 14 (8 SPS)* 
Table 1  Group formation and distribution of farm structures: S = sows, P = piglets, + = FQ use, - = no FQ use, SPS = part 
of a sow-pool-system, * = 14 farms received weaners from different groups (G1-G5) 
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Delivery 
 Groups    
G1 G2 G3 G4 G5     
farrowing unit 





2 weeks p.p. 
fecal samples  




4 weeks p.p 
fecal samples  
rearing unit single fecal samples   
   app. 10 weeks p.p 
 (2 weeks after moving 
into RU) 
fattening unit single fecal samples   
  app. 12 weeks p.p 







On every farm an approximate surface size of 0.06 sqm of unclean floors and 
walls from pens with sampled pigs were wiped with a gauze sponge moistened 
with sterile 0.85% saline solution. This was performed during sampling of each 
age category (two times in farrowing units, once in rearing and twice in fattening 
units). Additionally, a dust sample was collected in the same procedure from 
different horizontal surfaces (e.g. window sills, feed or water pipelines and lids of 
piglet nests) near the pens. From the slurry pit samples at different depths and 
with different consistency were mixed in a bucket. A homogenous sample of 
approximately 300 to 500 ml was taken and stored at - 20°C. After animal 
movement and the farmers’ individual cleaning procedures wipe and slurry 
samples were retaken. During the second visit in the farrowing barns (sampling of 
four-week old piglets) and in the fattening units with either continuous flow system 




Samples were thawed at 7°C overnight and tested semi-quantitatively for the 
presence of non-susceptible E. coli to quinolone. Approximately 1 g or 1 ml of 
sample was diluted 1:10 with 0.85% saline solution and homogenized in a 
Stomacher® (Seward Stomacher® 400 Laboratory Blender BA 7021, West 
Sussex, UK). The homogenate was streaken in different dilutions by the pour plate 
method on selective Rapid-E. coli 2 agar plates (Biorad®, Munich, Germany) 
supplemented with 8 mg/L nalidixic acid, 10 mg/L vancomycin and 5 mg/L 
amphotericin B. After overnight incubation at 37°C presumptive positive E. coli 
colonies (β-D-glucuronidase and β-D-galactosidase positive, presented as purple 
and round colonies) were counted. Plates with a massive E. coli growth making 
counting impossible were given an approximate number of 100’000 counts per 
plate. In assessing the rate of resistance in an animal stock results from a study 
only slightly differed between testing a single or multiple isolates per fecal sample 
[36]. Hence, from each sample one E. coli colony was randomly picked and 
stocked. Isolates underwent disk diffusion (DD) susceptibility testing including 
Figure 1 Fecal sampling: p.p. = postpartum, app. = approximately, RU = rearing unit, FU = fattening unit 
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antibiotics (Becton Dickinson and company, Sparks, MD USA) nalidixic acid 
(NA30) and ciprofloxacin (CIP5). In isolates intermediate and resistant to nalidixic 
acid, the minimal inhibitory concentration (MIC in μg/ml) to nalidixic acid and 
ciprofloxacin was assessed using ETEST® strips (BioMérieux, Marcy l'Etoile, 
France). Performance and interpretation of susceptibility testing followed the 
guidelines of the Clinical and Laboratory Standards Institute [37]. Due to a lack of 
animal specific breakpoints, MICs were interpreted according to human pathogen 
specific breakpoints published by Clinical and Laboratory Standards Institute [37] 
and by epidemiological cut-offs (ECOFFs Escherichia coli; ECOFFNalidixic acid: 8 
mg/L, ECOFFciprofloxacin: 0.064 mg/L) published by The European Committee on 
Antimicrobial Susceptibility Testing [38]. MIC values of nalidixic acid and 
ciprofloxacin were defined as intermediate resistant if lying between > 16 μg/ml 
and < 32 μg/ml and > 1 μg/ml and < 4 μg/ml, respectively. 
 
Data analysis and statistical evaluation 
 
Descriptive statistics and confidence intervals (95% CI) 
 
Descriptive and inferential statistics were performed in IBM® SPSS® Statistics for 
Macintosh Version 25.0 and the software program R Version 3.5.1 [39]. QNSE 
counts were expressed as log CFU/g or ml except zero QNSE counts (expressed 
as 0 CFU/g or ml). The number of samples with detection of QNSE divided by the 
total number of tested samples is described as detection rate (%). FQ 
susceptibility proportions (%) of isolated E. coli are described. Binomial and 
multinomial confidence intervals (95% CI) were obtained using Jeffreys approach 
[40] and MultinomCI() from the package by DescTools [41]. Non overlapping 
confidence intervals were considered to be significantly different.  
 
Mixed effects models 
 
A hurdle Poisson mixed effects model was used to assess if the counts of 
quinolone non-susceptible E. coli (QNSE) in weaners and fattening pigs (using the 
original size scales, for further information view annex) differed between the 
groups Trt (treated pigs; G1 and G3), Ctat (contact pigs; G2 and G4) and Ctrl 
(control pigs; G5, FQ free) with the package GLMMadaptive [42]. Because we did 
not have any influence on the distribution of weaners into the rearing units, the 
rearing units were integrated as a random effect. The detection of at least one 
QNSE is described as the outcome, i.e. as a “count”. Samples with zero QNSE 
counts are described as “zero count” and were tested in the zero-count part. The 
groups Trt, Ctat and Ctrl are described as the predictor variables, i.e. as fixed 
effects of the models. The hurdle models comprise two parts: the zero-count part 
is considered to be binomial (logistic regression) and the positive-count part is 
treated as a Poisson distribution. Additionally, models with a zero-inflated negative 
binomial distribution were also tested. Model fit was assessed by likelihood ratio 
tests. Additionally the factor “connection to a sow-pool-system” was included as 
fixed effect. QNSE count results from the mixed effects models (original size 





Demographic data of fecal samples (groups and age categories) 
 
In this study we included 218 pigs of which eleven pigs could not be followed up 
until the fattening unit (three pigs died, one pig was euthanized, seven pigs were 
undetectable). The greater part (n = 117, 53.7%) was born at farms which were 
connected to a sow-pool-system (SPS). Overall 621 fecal samples (116 fecal 
samples from two-week old piglets, 104 from four-week old piglets, 206 from pigs 
during rearing and 195 from fattening pigs) were tested and used for further 
analysis. In 40.9% (254/621) of fecal samples quinolone non-susceptible E. coli 
(QNSE) were detected (Table 2). Two-week old piglets showed the highest 
detection rate (94.0%, 109/116) followed by four-week old piglets (84.6%, 88/104), 
fattening pigs (15.6%, 35/195) and weaners (10.7%, 22/206). Confidence intervals 
differed between piglets (two- and four-week old, 95% CI = 76.7 - 97.3%) and 
weaners (95% CI = 7.0 - 15.5%) and piglets and fattening pigs (95% CI = 13.0-
23.8%), respectively. Detection rate of QNSE was lower in samples of weaners 
(10.7%, 95% CI = 7.0 - 15.5%) compared to samples of fattening pigs (15.6%, 
95% CI = 13.0 - 23.8%) but 95% CI did not differ significantly. QNSE were found 
to be existent in weaners and fattening pigs from farms without FQ use (G5 = 
7.8%, 7/90). Over all ages, the detection rate of QNSE was significantly lowest in 
G5 (7.8%, 95% CI = 3.5 - 14.7%) compared to G1 to G4 (36.9-54.2%, 95% CI = 
28.3 - 62.2%). In the farrowing unit contact animals (G2 and G4) showed similar or 
higher detection rates compared to treated piglets and piglets from treated sows 
(G3 and G1) but with overlapping 95% CI. In the rearing unit detection rates 
decreased in all groups (G1-G4) but reincreased in three groups (G1, G3, G4) two 
to ten times during the fattening unit. In group 5 no increase of the detection rate 
was observed between the rearing and the fattening unit. However, there were no 
significant differences concerning the 95% CI between groups 1 to 5 comparing 
  
Groups  










94.4% (17/18), p 
CI = 76.8 - 99.4% 
x0 = 1 
ø = 7.0 
m = 6.6 
100.0% (18/18), p 
CI = 87.1 - 100.0% 
x0 = 0 
ø = 6.7 
m = 5.8 
92.5% (37/40)  
CI = 81.3 - 97.9% 
x0 = 3 
ø = 7.1 
m = 5.6 
92.5% (37/40)  
CI = 81.3 - 97.9% 
x0 = 3 
ø = 5.8 
m = 4.6 
 
94.0% (109/116) 
CI = 88.5 - 97.3% 
x0 = 7 
ø = 6.9 






94.1% (16/17), p 
CI = 75.6 - 99.4% 
x0 = 1 
ø = 6.4 
m = 5.1 
91.7% (11/12), p 
CI = 67.1 - 99.1% 
x0 = 1 
ø = 6.4 
m = 6.3 
72.5% (29/40) 
CI = 57.4 - 84.5% 
x0 = 11 
ø = 5.4 
m = 3.8 
91.4% (32/35) 
CI = 78.8 - 97.6% 
x0 = 3 
ø = 5.1 
m = 3.8 
84.6% (88/104) 
CI = 76.7 - 90.6% 
x0 = 16 
ø = 5.9 
m = 4.3 
RU 
13.3% (6/45) 
CI = 5.7 - 25.5% 
x0 = 39 
ø = 2.3 
m = 0.0 
15.4% (6/39) 
CI = 6.6 - 29.0% 
x0 = 33 
ø = 3.1 
m = 0.0 
10.8% (4/37) 
CI = 3.7 - 23.7% 
x0 = 33 
ø = 1.0 
m = 0.0 
2.5% (1/40) 
CI = 0.2 - 11.1% 
x0 = 39 
ø = 3.4 
m = 0.0 
11.1% (5/45) 
CI = 4.3 - 22.7% 
x0 = 40 
ø = 1.7 
m = 0.0 
10.7% (22/206) 
CI = 7.0 - 15.5% 
x0 = 184 
ø = 2.9 
m = 0.0 
FU 
23.8% (10/42) 
CI = 12.9 - 38.2% 
x0 = 32 
ø = 2.9 
m = 0.0 
14.3% (6/42) 
CI = 6.1 - 27.1% 
x0 = 36 
ø = 2.3 
m = 0.0 
29.6% (8/27) 
CI = 15.1 - 48.3% 
x0 = 19 
ø = 2.2 
m = 0.0 
25.0% (9/39) 
CI = 12.0 - 38.0% 
x0 = 30 
ø = 2.1 
m = 0.0 
4.4% (2/45) 
CI = 0.9 - 13.6% 
x0 = 43 
ø = 1.9 
m = 0.0 
15.6% (35/195) 
CI = 13.0 - 23.8% 
x0 = 160 
ø = 2.5 
m = 0.0 
TOTAL 
40.2% (49/122) 
CI = 31.7 - 49.1% 
x0 = 73 
ø = 6.3 
m = 0.0 
36.9% (41/111) 
CI = 28.3 - 46.2% 
x0 = 70 
ø = 6.1 
m = 0.0 
54.2% (78/144) 
CI = 46.0 - 62.2% 
x0 = 66 
ø = 6.6 
m = 100.0 
51.3% (79/154) 
CI = 43.4 - 59.2% 
x0 = 75 
ø = 5.3 
m = 100.0 
7.8% (7/90) 
CI = 3.5 - 14.7% 
x0 = 83 
ø = 1.8 
m = 0.0 
40.9% (254/621) 
CI = 37.0 - 44.9% 
x0 = 367 
ø = 6.2 
m = 0.0 
Table 2 Detection rates and corresponding 95% confidence intervals (CI), x0 = number of samples with zero quinolone non-
susceptible E. coli detected, mean (= ø) and median (= m) log colony forming unit per gram feces (log CFU/g) of quinolone 
non-susceptible E.coli in fecal samples from pigs of different age and group, median = 0.0 were expressed in colony forming 
unit per gram feces (CFU/g), FARU = farrowing unit, 2/4w p.p. = two and four weeks postpartum, RU = rearing unit, FU = 
fattening unit, p = pooled samples 
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age. Detection rates in weaners (SPS+: 11.8%, 95% CI: 6.7 - 18.9%, SPS-: 9.4%, 
95% CI: 4.7 - 16.5%) and fattening pigs (SPS+: 15.7%, 95% CI: 9.6 - 23.7%, SPS-
: 20.4%, 95% CI: 13.2 - 29.5%) did not differ depending on the connection to a 
SPS. From piglets to fattening pigs there is a decrease in mean and median log 
counts of quinolone non-susceptible E. coli colony forming units per gram feces 
(log CFU/g feces). Highest means were detected in two-week old piglets from G3 
(ø = 7.1 log CFU/g feces) and G1 (ø = 7.0 log CFU/g feces). In the rearing and 
fattening unit, the lowest means were observed in G3 (ø = 1.0 log CFU/g feces) 
and G5 (ø = 1.9 log CFU/g feces). According to the route of antibiotic application 
during suckling period (intramuscularly vs. perorally) detection rates did not differ 
significantly (overlapping 95% CIs) in the farrowing (two-week old piglets: 93.8% 
(i.m., 95% CI = 74.3 - 99.4%) and 91.7% (p.o., 95% CI = 75.8 - 98.3%), four-week 
old piglets: 87.5% (i.m., 95% CI = 65.5 - 97.4%) and 62.5% (p.o., 95% CI = 42.6 - 
79.6%)), rearing (weaner: 13.3% (i.m., 95% CI = 2.8 - 36.4%) and 9.1% (p.o., 95% 
CI = 1.9 - 26.1%)) and fattening unit (fattening pigs: 12.5% (i.m., 95% CI = 1.3 - 
45.4%) and 36.8% (p.o., 95% CI = 18.2 - 59.2%)). 
 
Quantitative and qualitative detection of QNSE – hurdle models 
 
The factor “connection to a sow-pool-system” was excluded after the hurdle 
models were not converging including this factor. The lowest means of colony 
forming units per gram feces in weaners and fattening pigs were observed in 
group Ctrl (control group; G5, weaner: ø = 1.7 log CFU/g feces; fattening pig: ø = 
1.9 log CFU/g feces) compared to group Trt (treated pigs; G1 and G3, weaner: ø = 
2.1 log CFU/g feces; fattening pig: ø = 2.8 log CFU/g feces) and group Ctat 
(contact pigs; G2 and G4, weaner: ø = 3.3 log CFU/g feces; fattening pig: ø = 2.2 
log CFU/g feces). The Poisson hurdle model with random effects indicated 
significant differences in the count part, i.e. in quantitative detection of QNSE 
significant differences between groups were observed in weaners and fattening 
pigs (highlighted with an asterisk in Table 3). In the zero-part, i.e. detection of 
QNSE versus no detection of QNSE, no significant differences were observed 
between the three groups in weaners. In fattening pigs, values showed large 
standard errors and therefore were not plausible. Concerning the means and 
count parts between weaners and fattening pigs, there is a significant increase in 
log colony forming units per gram feces in group Trt and Ctrl. Group Ctat showed 
 group 







mean 2.1 3.3 1.7 



























mean 2.8 2.2 1.9 

















Table 3  Hurdle models: x0 = number of samples with zero QNSE detected, mean, hurdle models with count and zero part 
and confidence intervals (CI 95%) in log CFU/g feces. Trt = treated group (G1 and G3), Ctat = contact group (G2 and G4), 
Ctrl = control group (G5), * = significant values (not overlapping confidence intervals), # = indicates not convertible hurdle 
models with large and non-useful standard errors 
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significantly lower counts of log colony forming units per gram feces in fattening 
pigs compared to weaners. For further information view Table 3. 
 
 
Minimal inhibitory concentration (MIC) data of fecal samples 
 
Nalidixic acid (NA) 
 
Minimal inhibitory concentration was tested in 254 isolates of which the MIC 50% 
and 90% of NA were > 256 µg/ml. Except for three isolates all of the piglets’ 
isolates of G3 and G4 achieved MICs between 256 and > 256 µg/ml. Isolates’ 
MICs of G1 and G2 showed a wider range (24 - > 256 µg/ml) in piglets. Observing 
all ages isolates of G3 (n = 78), G4 (n = 79) and G5 (n = 7) reached the same MIC 
50% and 90% (> 256 µg/ml). Further information can be obtained from Table 4. 
Out of all fecal isolates 98.4% (250/254) were resistant to nalidixic acid according 
to CLSI guidelines. Four isolates (1.6%) showed intermediate resistant results 
(Table 5). 
group and age 





24 48 64 96 128 192 256 >256    
G1 all ages 2 0 0 5 3 6 13 20 49 256 >256 
G1 piglet2w 0 0 0 4 3 1 6 3 17 256 >256 
G1 piglet4w 1 0 0 1 0 4 1 9 16 >256 >256 
G1 weaner 1 0 0 0 0 0 1 4 6 >256 >256 
G1 fattening pig 0 0 0 0 0 1 5 4 10 >256 >256 
G2 all ages 1 0 1 4 4 6 11 14 41 256 >256 
G2 piglet2w 0 0 1 2 2 3 3 7 18 256 >256 
G2 piglet4w 1 0 0 2 2 1 1 4 11 192 >256 
G2 weaner 0 0 0 0 0 2 4 0 6 256 256 
G2 fattening pig 0 0 0 0 0 0 3 3 6 >256 >256 
G3 all ages 1 1 0 0 0 0 14 62 78 >256 >256 
G3 piglet2w 1 0 0 0 0 0 1 35 37 >256 >256 
G3 piglet4w 0 1 0 0 0 0 5 23 29 >256 >256 
G3 weaner 0 0 0 0 0 0 0 4 4 >256 >256 
G3 fattening pig 0 0 0 0 0 0 8 0 8 256 256 
G4 all ages 0 0 1 0 0 0 35 43 79 >256 >256 
G4 piglet2w 0 0 1 0 0 0 16 20 37 >256 >256 
G4 piglet4w 0 0 0 0 0 0 11 21 32 >256 >256 
G4 weaner 0 0 0 0 0 0 0 1 1 >256 >256 
G4 fattening pig 0 0 0 0 0 0 8 1 9 256 >256 
G5 all ages 0 0 0 0 0 0 1 6 7 >256 >256 
G5 weaner 0 0 0 0 0 0 1 4 5 >256 >256 





















Table 4  Nalidixic acid MIC distribution by group and age: Numbers indicate the number of strains exhibiting the corresponding 
MIC value. Yellow and red areas indicate the intermediate and resistant isolates, respectively. Breakpoints were obtained 
from the CLSI guidelines 2017 for human breakpoints. MIC 50% and MIC 90% represent the concentration of nalidixic acid 







MIC 50% and 90% of all the tested isolates were 0.38 and > 32 µg/ml 
ciprofloxacin. In isolates of G3 a markedly higher MIC 50% (8 µg/ml) was 
observed compared to G1, G2, G4 and G5 (0.125 - 0.25 µg/ml). Considering age 
categories piglets’ and weaners’ MIC 50% is more beneficial in isolates of G1, G2 
and G5 compared to G3 and G4. In fattening pigs MIC 50% of all groups (G1-G5) 
decreased to 0.19 µg/ml. Overall 128 isolates were susceptible to ciprofloxacin 
(50.4%). The major part of isolates susceptible to ciprofloxacin (103/128, 80.5%) 
showed MICs lying between 0.125 and 0.19 µg/ml (Table 7, see next page). 
According to the wildtype’s MIC (0.064 µg/ml) by EUCAST decreased 
susceptibility to ciprofloxacin was observed in 133 isolates (133/134, 99.3%). 
Ciprofloxacin resistant isolates were mostly represented in G3 and G4 (60/120, 
50.0% and 36/120, 30.0%). Only seven quinolone resistant isolates were observed 
in G5, two isolates showed intermediate and complete resistance against 
ciprofloxacin (MIC = 3 and 4 µg/ml). All seven isolates originated from the same 
farm on which the last FQ usage was carried out three months ago. Further 
information can be obtained from Table 6.  
 
group CLSI EUCAST decreased 
susceptibility 
TOTAL 
I (CI 95%) R (CI 95%) WT (CI 95%) M (CI 95%) DS 
G1 4.1%, n = 2 
(0.8 - 12.5%) 
95.9%, n = 47 
(87.5 - 99.2%) 
0.0%, n = 0 
(0.0 - 5.0%) 
100.0%, n = 49 
(95.0 - 100.0%) 
4.1%, n = 2 
(0.8 - 12.5%) 
49 (19.3%) 
G2 2.4%, n = 1 
(0.2 - 10.9%) 
97.6%, n = 40 
(89.1 - 99.8%) 
0.0%, n = 0 
(0.0 - 6.0%) 
100.0%, n = 41 
(94.0 - 100.0%) 
2.4%, n = 1 
(0.2 - 10.9%) 
41 (16.1%) 
G3 1.3%, n = 1 
(0.1 - 5.9%) 
98.7%, n = 77 
(94.1 - 99.9%) 
0.0%, n = 0 
(0.0 - 3.2%) 
100.0%, n = 78 
(96.8 - 100.0%) 
1.3%, n = 1 
(0.1 - 5.9%) 
78 (30.7%) 
G4 0.0%, n = 0 
(0.0 - 3.2%) 
100.0%, n = 79 
(96.8 - 100.0%) 
0.0%, n = 0 
(0.0 - 3.2%) 
100.0%, n = 79 
(96.8 - 100.0%) 
0.0%, n = 0 
(0.0 - 3.2%) 
79 (31.1%) 
G5 0.0%, n = 0 
(0.0 - 29.3%) 
100.0%, n = 7 
(70.7 - 100.0%) 
0.0%, n = 0 
(0.0 - 29.3%) 
100.0%, n = 7 
(70.7 - 100.0%) 
0.0%, n = 0 
(0.0 - 29.3%) 
7 (2.8%) 
TOTAL 1.6%, n = 4 
(0.5 - 3.8%) 
98.4%, n = 250 
(96.2 - 99.5%) 
0%, n = 0 
(0.0 - 1.0%) 
100%, n = 254 
(99.0 - 100.0%) 
1.6%, n = 4 






S (CI 95%) I (CI 95%) R (CI 95%) WT (CI 95%) M (CI 95%) DS 
G1 
69.4%, n = 34 
(55.5 - 80.5%) 
6.1%, n = 3 
(2.1 - 16.5%) 
24.5%, n = 12 
(14.6 - 38.1%) 
2.1%, n = 1 
(0.2 - 9.2%) 
97.9%, n = 48 
(90.8 - 99.8) 
73.5%, n = 36 




70.8%, n = 29 
(55.5 - 82.4%) 
2.4%, n = 1 
(0.4 - 12.6%) 
26.8%, n = 11 
(15.7 - 41.9%) 
0.0%, n = 0 
(0.0 - 6.0%) 
100.0%, n = 41 
(94.0 - 100.0%) 
73.2%, n = 30 




23.1%, n = 18 
(15.1 - 33.6%) 
0.0%, n = 0 
(0.0 - 4.7%) 
76.9%, n = 60 
(66.4 - 84.9%) 
0.0%, n = 0 
(0.0 - 3.2%) 
100.0%, n = 78 
(96.8 - 100.0%) 
23.1%, n = 18 




53.2%, n = 42 
(42.3 - 63.8) 
1.3%, n = 1 
(0.2 - 6.8) 
45.6%, n = 36 
(35.0 - 56.5%) 
0.0%, n = 0 
(0.0 - 3.2%) 
100.0%, n = 79 
(96.8 - 100.0%) 
54.4%, n = 43 




71.4%, n = 5 
(35.9 - 91.8%) 
14.3%, n = 1 
(2.6 - 51.3%) 
14.3%, n = 1 
(2.6 - 51.3%) 
0.0%, n = 0 
(0.0 - 29.3%) 
100.0%, n = 7 
(70.7 - 100.0%) 
85.7%, n = 6 




50.4%, n = 128 
(44.3 - 56.5%) 
2.4%, n = 6 
(1.2 - 5.1%) 
47.2%, n = 120 
(41.2 - 53.4%) 
0.4%, n = 1 
(0.0 - 1.9%) 
99.6%, n = 253 
(98.1 - 100.0%) 
52.4%, n = 133 
(46.2 - 58.5%) 
254 
(100%) 
Table 5  Nalidixic acid MICs interpretation: Proportions (%) and the corresponding confidence intervals in brackets. N = 
number of strains. Yellow and red areas indicate the intermediate and resistant isolates according to the CLSI guidelines 
2017 for human breakpoints. WT and M indicate the numbers of strains classified as wildtype or mutant strain according to 
the EUCAST guidelines 2019. Strains with decreased susceptibility are strains lying between the wildtype’s MIC (EUCAST) 
and the resistant MIC (CLSI). 
Table 6  Ciprofloxacin MICs interpretation: Proportions (%) and the corresponding 95% confidence intervals in brackets (). 
N = number of strains. Light green, yellow and red areas indicate the sensible, intermediate and resistant isolates according 
to the CLSI guidelines 2017 for human breakpoints. WT and M indicate the numbers of strains classified as wildtype or 
mutant strain according to the EUCAST guidelines 2019. Strains with decreased susceptibility are strains lying between the 




group and age 





0.047 0.094 0.125 0.19 0.25 0.38 3 4 6 8 12 24 32 >32    
G1 all ages 1 5 22 6 0 0 3 3 3 2 0 0 1 3 49 0.125 8 
G1 piglet2w 0 1 11 2 0 0 1 0 0 0 0 0 0 2 17 0.125 >32 
G1 piglet4w 0 4 4 1 0 0 2 2 1 0 0 0 1 1 16 0.19 >32 
G1 weaner 1 0 2 1 0 0 0 1 1 0 0 0 0 0 6 0.19 6 
G1 fattening pig 0 0 5 2 0 0 0 0 1 2 0 0 0 0 10 0.19 8 
G2 all ages 0 8 14 6 1 0 1 3 2 1 0 0 2 3 41 0.125 32 
G2 piglet2w 0 2 7 2 0 0 1 2 1 0 0 0 0 3 18 0.19 >32 
G2 piglet4w 0 5 2 0 1 0 0 1 0 0 0 0 2 0 11 0.125 32 
G2 weaner 0 0 4 2 0 0 0 0 0 0 0 0 0 0 6 0.125 0.19 
G2 fattening pig 0 1 1 2 0 0 0 0 1 1 0 0 0 0 6 0.19 8 
G3 all ages 0 0 6 11 1 0 0 1 19 12 0 2 9 17 78 8 >32 
G3 piglet2w 0 0 2 0 0 0 0 1 4 10 0 2 7 11 37 24 >32 
G3 piglet4w 0 0 2 6 0 0 0 0 14 2 0 0 1 4 29 6 >32 
G3 weaner 0 0 0 0 0 0 0 0 1 0 0 0 1 2 4 >32 >32 
G3 fattening pig 0 0 2 5 1 0 0 0 0 0 0 0 0 0 8 0.19 0.25 
G4 all ages 0 5 13 20 2 2 1 0 18 4 1 0 0 13 79 0.25 >32 
G4 piglet2w 0 5 5 8 0 2 0 0 2 4 1 0 0 10 37 0.38 >32 
G4 piglet4w 0 0 7 5 1 0 1 0 15 0 0 0 0 3 32 6 32 
G4 weaner 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 6 6 
G4 fattening pig 0 0 1 7 1 0 0 0 0 0 0 0 0 0 9 0.19 0.25 
G5 all ages 0 0 2 3 0 0 1 1 0 0 0 0 0 0 7 0.19 4 
G5 weaner 0 0 1 2 0 0 1 1 0 0 0 0 0 0 5 0.19 4 

































Table 7  Ciprofloxacin MIC distribution by group and age: Numbers indicate the number of strains exhibiting the corresponding MIC value. Light green, yellow and red areas indicate the sensible, intermediate 
and resistant isolates, respectively. Breakpoints were obtained from the CLSI guidelines 2017 for human breakpoints. MIC 50% and MIC 90% represent the concentration of ciprofloxacin (μg/ml) inhibiting 
growth of 50% or 90% of strains, respectively. Piglet2w = two-week old piglet, piglet4w = four-week old piglet 
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NA and CIP susceptibility proportions (groups and age categories) 
 
Nalidixic acid susceptibility proportions were similar in weaners and fattening pigs of 
G1 to G4 and Trt (S = 0.0%, 95% CI = 0.0 - 85.4%, R = 100.0%, 95% CI = 14.6 - 
100.0%), Ctat and Ctrl (S = 0.0%, 95% CI = 0.0 - 66.7%, R = 100.0%, 95% CI = 33.3 
- 100.0%). Ciprofloxacin susceptibility proportions in weaners of G2 (S = 100.0%, 
95% CI = 66.9 - 100.0%, R = 0.0%, 95% CI = 0.0 - 33.1%) and G3 (S = 0.0%, 95% CI 
= 0.0 - 44.5%, R = 100.0%, 95% CI = 55.5 - 100.0%) differed significantly but in 
group Trt, Ctat and Ctrl (S = 40.0 - 85.7%, 95% CI = 15.3 - 98.5%, R = 14.3 - 60.0%, 
95% CI = 1.5 - 84.7%) no significantly different susceptibility proportions were 
observed. In fattening pigs of G1 to G5 (S = 66.7 - 100.0%, 95% CI = 28.6 - 100.0%, 
R = 0.0 - 33.3%, 95% CI = 0.0 - 71.4%) and Trt, Ctat and Ctrl (S = 83.3 - 100.0%, 
  G1 G2 G3 G4 G5 
NA weaner 
S = 0.0%, n = 0 
(0.0 - 33.1%) 
R = 100.0%, n = 6 
(66.9 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 33.1%) 
R = 100.0%, n = 6 
(66.9 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 44.5%) 
R = 100.0%, n = 4 
(55.5 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 85.4%) 
R = 100.0%, n = 1 
(14.6 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 38.0%) 
R = 100.0%, n = 5 
(62.0 - 100.0%) 
NA fattening pig 
S = 0.0%, n = 0 
(0.0 - 21.8%) 
R = 100.0%, n = 10 
(78.2 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 33.1%) 
R = 100.0%, n = 6 
(66.9 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 26.3%) 
R = 100.0%, n = 8 
(73.7 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 23.8%) 
R = 100.0%, n = 9 
(76.2 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 66.7%) 
R = 100.0%, n = 2 
(33.3 - 100.0%) 
CIP weaner 
S = 66.7%, n = 4 
(28.6 - 92.4%) 
R = 33.3%, n = 2 
(7.6 - 71.4%) 
S = 100.0%, n = 6 
(66.9 - 100.0%)  
R = 0.0%, n = 0 
(0.0 - 33.1%) 
S = 0.0%, n = 0 
(0.0 - 44.5%) 
R = 100.0%, n = 4 
(55.5 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 85.4%) 
R = 100.0%, n = 1 
(14.6 - 100.0%) 
S = 60.0%, n = 3 
(20.9 - 90.6%) 
R = 40.0%, n = 2 
(9.4 - 79.1%) 
CIP fattening pig 
S = 70.0%, n = 7 
(39.4 - 90.8%) 
R = 30.0%, n = 3 
(9.2 - 60.6%) 
S = 66.7%, n = 4 
(28.6 - 92.4%) 
R = 33.3%, n = 2 
(7.6 - 71.4%) 
S = 100.0%, n = 8 
(73.7 - 100.0%) 
R = 0.0%, n = 0 
 (0.0 - 26.3%) 
S = 100.0%, n = 9 
(76.2 - 100.0%) 
R = 0.0%, n = 0 
(0.0 - 23.8%) 
S = 100.0%, n = 2 
(33.3 - 100.0%) 
R = 0.0%, n = 0 
(0.0 - 66.7%) 
  Trt Ctat Ctrl     
NA weaner 
S = 0.0%, n = 0 
(0.0 - 21.8%) 
R = 100.0%, n = 10 
(78.2 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 29.3%) 
R = 100.0%, n = 7 
(70.7 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 38.0%) 
R = 100.0%, n = 5 
(62.0 - 100.0%) 
  
NA fattening pig 
S = 0.0%, n = 0 
(0.0 - 12.9%) 
R = 100.0%, n = 18 
(87.1 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 15.2%) 
R = 100.0%, n = 15 
(84.8 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 66.7%) 
R = 100.0%, n = 2 
(33.3 - 100.0%) 
  
CIP weaner 
S = 40.0%, n = 4 
(15.3 - 69.7%) 
R = 60.0%, n = 6 
(30.3 - 84.7%) 
S = 85.7%, n = 6 
(49.9 - 98.5%)  
R = 14.3%, n = 1 
(1.5 - 50.1%) 
S = 60.0%, n = 3 
(20.9 - 90.6%) 
R = 40.0%, n = 2 
(9.4 - 79.1%) 
  
CIP fattening pig 
S = 83.3%, n = 15 
(61.8 - 95.1%) 
R = 16.7%, n = 3 
(4.9 - 38.2%) 
S = 86.7%, n = 13 
(63.6 - 97.2%) 
R = 13.3%, n = 2 
(2.8 - 36.4%) 
S = 100.0%, n = 2 
(33.3 - 100.0%) 
R = 0.0%, n = 0 
(0.0 - 66.7%) 
  
  part of SPS not part of SPS       
NA weaner 
S = 0.0%, n = 0 
(0.0 - 17.3%) 
R = 100.0%, n = 13 
(82.7 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 23.8%) 
R = 100.0%, n = 9 
(76.2 - 100.0%) 
   
NA fattening pig 
S = 0.0%, n = 0 
(0.0 - 14.4%) 
R = 100.0%, n = 16 
(85.6 - 100.0%) 
S = 0.0%, n = 0 
(0.0 - 12.3%) 
R = 100.0%, n = 19 
(87.7 - 100.0%) 
   
CIP weaner 
S = 61.5%, n = 8 
(35.0 - 83.6%) 
R = 38.5%, n = 5 
(16.4 - 65.0%) 
S = 44.4%, n = 4 
(17.2 - 74.6%) 
R = 55.6%, n = 5 
(25.4 - 82.8%) 
   
CIP fattening pig 
S = 68.7%, n = 11 
(44.4 - 87.0%) 
R = 31.3%, n = 5 
(13.0 - 55.6%) 
S = 100.0%, n = 19 
(87.7 - 100.0%) 
R = 0.0%, n = 0 
(0.0 - 12.3%) 
   
Table 8  Minimal inhibitory concentrations (µg/ml) of nalidixic acid (NA) and ciprofloxacin (CIP) are classified as sensible (S) 
and resistant (intermediate and resistant summarized = R) isolates according to CLSI guidelines 2017 for human breakpoints 
with the corresponding 95% confidence intervals in brackets (), n = number of isolates originating from weaners and fattening 
pigs, SPS = sow-pool-system 
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95% CI = 33.3 - 100.0%, R = 0.0 - 16.7%, 95% CI = 0.0 - 66.7%) no differences were 
observed (Table 8). 
NA and CIP susceptibility proportions (connection to sow-pool-system) 
 
Fattening pigs originating from farms connected to a sow-pool-system had a 
significantly higher ciprofloxacin resistance rate (R = 31.3%, 95% CI = 13.0 - 55.6%) 
compared to fattening pigs of farms without SPS-connection (R = 0.0%, 95% CI = 0.0 
- 12.3%). For further information see table 8. 
 
Demographic data of environmental samples 
 
130 wipe samples (67 dust and 63 pen samples) and 49 slurry samples were tested 
(179 environmental samples) and used for further analysis. Of all environmental 
samples 14.0% (25/179) showed growth of QNSE. Floor and wall wipes reached the 
highest detection rate (23.8%, 15/63), followed by slurry (18.4%, 9/49) and dust 
(1.5%, 1/67). In the farrowing unit 29.4% (10/34) of the environmental samples 
contained QNSE. From farrowing to fattening unit the detection rate declined (33.3% 
to 10.7%). After individual cleaning in the fattening unit, in four of 50 environmental 
samples (8.0%) QNSE were detected. The environmental samples of the farrowing 















CI = 0.0 - 26.3% 
x0 = 8 
66.7% (4/6) 
CI = 28.6 - 92.4% 
x0 = 2 
ø = 3.0 
m = 3.0 
50.0% (2/4) 
CI = 12.2 - 87.8% 
x0 = 2 
ø = 3.6 
m = 2.0 
33.3% (6/18) 
CI = 15.2 - 56.3% 
x0 = 12 
ø = 3.1 







CI = 1.2 - 41.5% 
x0 = 8 
ø = 3.9                 
m = 0.0 
42.9% (3/7) 
CI = 13.8 - 76.6% 
x0 = 4 
ø = 3.2 
m = 0.0 
 
25.0% (4/16) 
CI = 9.0 - 49.1% 
x0 = 12 
ø = 3.7 
m = 0.0 
RU 
0.0% (0/13) 
CI = 0.0 - 23.8% 
x0 = 13 
7.7% (1/13) 
CI = 0.8 - 30.8% 
x0 = 12 
ø = 0.9 
m = 0.0 
30.8% (4/13) 
CI = 11.3 - 57.8% 
x0 = 9 
ø = 3.0 
m = 0.0 
12.8% (5/39) 
CI = 5.0 - 25.9% 
x0 = 34 
ø = 2.5 
m = 0.0 
FU 
0.0% (0/19) 
CI = 0.0 - 12.3% 
x0 = 19 
21.1% (4/19) 
CI = 7.5 - 42.7% 
x0 = 15 
ø = 2.0 
m = 0.0 
11.1% (2/18) 
CI = 2.3 - 31.2% 
x0 = 16 
ø = 2.5 
m = 0.0 
10.7% (6/56) 
CI = 4.5 - 20.8% 
x0 = 50 
ø = 2.2 




CI = 0.0 - 12.9% 
x0 = 18 
16.7% (3/18) 
CI = 4.9 - 38.2% 
x0 = 15 
ø = 3.0 
m = 0.0 
7.1% (1/14) 
CI = 0.7 - 28.9% 
x0 = 13 
ø = 1.2 
m = 0.0 
8.0% (4/50) 
CI = 2.7 - 18.0% 
x0 = 46 
ø = 2.6 
m = 0.0 
TOTAL 
1.5% (1/67) 
CI = 0.1 - 6.8% 
x0 = 66 
ø = 3.0 
m = 0.0 
23.8% (15/63) 
CI = 14.6 - 35.4% 
x0 = 48 
ø = 2.8 
m = 0.0 
18.4% (9/49) 
CI = 9.4 - 30.9% 
x0 = 40 
ø = 2.8 
m = 0.0 
14.0% (25/179) 
CI = 9.4 - 19.7% 
x0 = 154 
ø = 2.9 
m = 0.0 
Table 9  Detection rates and corresponding 95% confidence intervals (CI), x0 = number of samples with zero QNSE detected, 
mean (= ø) and median (= m) log colony forming unit per gram dust or wipe or per milliliter slurry (log CFU/g or log CFU/ml) 
of QNSE in environmental samples from different farm units, median = 0.0 were expressed in colony forming unit per gram 




Minimal inhibitory concentration (MIC) data of environmental samples 
 
MIC 50% and 90% of nalidixic acid for all environmental isolates reached the upper 
measuring limit (> 256 µg/ml). Ciprofloxacin’s MIC 90% was > 32 µg/ml but MIC 50% 
was low (0.25 µg/ml). The MIC range of nalidixic acid and ciprofloxacin were both 
wide in wipe (n=15) and slurry isolates (n=9) (Table 10). According to CLSI 88.0% 
(22/25) and 36.0 % (9/25) of environmental isolates were resistant to nalidixic acid 
and ciprofloxacin, respectively. Most of these isolates were found in wipe samples 
(13/15 and 8/15). Of the 15 ciprofloxacin susceptible isolates 12 (12/15, 80.0%) 










24 32 64 96 256 >256    
dust 0 0 1 0 0 0 1 64 64 
wipes 2 1 0 1 2 9 15 >256 >256 


















concentrations of ciprofloxacin in µg/ml  
0.047 0.125 0.19 0.25 0.38 4 6 8 24 >32  
dust 0 0 0 1 0 0 0 0 0 0 1 0.25 0.25 
wipes 1 0 5 0 1 2 1 2 1 2 15 4 >32 































I R WT M DS 
dust 
0.0%, n = 0 
(0.0 - 85.4%) 
100.0%, n = 1 
(14.6 - 100.0%) 
0.0%, n = 0 
(0.0 - 85.4%) 
100.0%, n = 1 
(14.6 - 100.0%) 
0.0%, n = 0 





(2.8 - 36.4%) 
86.7%, n = 13 
(63.6 - 97.2%) 
0.0%, n = 0 
(0.0 - 15.2%) 
100.0%, n = 15 
(84.8 - 100.0%) 
0.0%, n = 0 





(1.2 - 41.5%) 
88.9%, n = 8 
(58.5 - 98.8%) 
0.0%, n = 0 
(0.0 - 23.8%) 
100.0%, n = 9 
(76.2 - 100.0%) 
0.0%, n = 0 





(3.4 - 28.7%) 
88.0%, n = 22 
(71.3 - 96.6%) 
0.0%, n = 0 
(0.0 - 9.5%) 
100%, n = 25 
(90.5 - 100.0%) 
0.0%, n = 0 
(0.0 - 9.5%) 
25 
(100%) 
 ciprofloxacin  
dust 
100.0%, n = 1 
(20.7 - 100.0%) 
0.0%, n = 0 
(0.0 - 79.3%) 
0.0%, n = 0 
(0.0 - 79.3%) 
0.0%, n = 0 
(0.0 - 85.4%) 
100.0%, n = 1 
(14.6 - 100.0%) 
100.0%, n = 1 




46.7%, n = 7 
(24.8 - 69.9%) 
6.6%, n = 1 
(1.2 - 29.8%) 
46.7%, n = 7 
(24.8 - 69.9%) 
6.6%, n = 1 
(0.7 - 27.2%) 
93.4%, n = 14 
(82.8 - 99.3%) 
26.7%, n = 4 




77.8%, n = 7 
(45.2 - 93.7%) 
0.0%, n = 0 
(0.0 - 29.9%) 
22.2%, n = 2 
(6.3 - 54.7%) 
0.0%, n = 0 
(0.0 - 23.8%) 
100.0%, n = 9 
(76.2 - 100.0%) 
77.8%, n = 7 




60.0%, n = 15 
(40.7 - 76.6%) 
4.0%, n = 1 
(0.7 - 19.5%) 
36.0%, n = 9 
(20.2 - 55.5%) 
4.0%, n = 1 
(0.4-17.3%) 
96.0%, n = 24 
82.7-99.6%) 




Table 11  Nalidixic acid and ciprofloxacin MICs interpretation: Proportions (%) and the corresponding 95% confidence 
intervals in brackets (). N = number of strains. Light green, yellow and red areas indicate the sensible, intermediate and 
resistant isolates according to the CLSI guidelines 2017 for human breakpoints. WT and M indicate the numbers of strains 
classified as wildtype or mutant strain according to the EUCAST guidelines 2019. Strains with decreased susceptibility are 
strains lying between the wildtype’s MIC (EUCAST) and the resistant MIC (CLSI). 
Table 10  Nalidixic acid and ciprofloxacin MIC distribution by sample: Numbers indicate the number of strains exhibiting the 
corresponding MIC value. Light green, yellow and red areas indicate the sensible, intermediate and resistant isolates, 
respectively. Breakpoints were obtained from the CLSI guidelines 2017 for human breakpoints. MIC50 and MIC90 represent 





Limitations of the study 
 
Sampling was performed after a recently introduced law revision concerning more 
restrictive requirements for veterinary prescriptions of FQ on pig farms [8]. Therefore, 
only a small number of farrowing units (two farrow-to-finish, three farrow and rearing 
and two farrowing farms) were left meeting our inclusion criteria which could have 
caused a selection bias. Further, a good mixing of various farm sizes was not 
achieved sampling farms which were mostly small to medium-sized. In previous 
studies investigating FQ resistance in pigs animal husbandry and FQ treatment were 
managed by the study investigators which is why we chose our study to be carried 
out under field conditions [31, 32, 43]. This included FQ treatment performed by the 
individual farmers who used different FQ products and different prescriptions (single 
versus multiple treatments) according to their private veterinarian. Treated and 
contact animals were either held in the same pen or room. Besides other farm-
specific effects, these differences could have had some impact on our results, e.g. 
different treatment schemes could lead to variable detection rates, counts of 
quinolone non-susceptible E. coli and minimal inhibitory concentrations of 
ciprofloxacin. Treatment of dams or piglets was mostly performed shortly after birth 
due to postpartum dysgalactia syndrome (PPDS). Collecting necessary amounts of 
feces of newly born piglets for the laboratory methods used is almost impossible. 
Due to these limitations control sampling of piglets before treatment was not 
performed. Taking rectal swabs would be an alternative for future projects [32]. A 
previous study investigated the occurrence of QNSE in dams of the piglets included 
in this study (G1 and G2). In all dams control sampling was performed shortly after 
entry into the farrowing unit and before any FQ treatment. They found equal 
detection rates of QNSE (33.3%, 10 out of 30 dams) in both groups (dams FQ 
treated and dams not FQ treated) before FQ treatment [44]. Import and vertical 
transmission of quinolone resistant E. coli in hatcheries without antibiotic selective 
pressure was recently published [45]. Enrofloxacin and ciprofloxacin concentrations 
were measurable in blood serum samples of control weaners grouped together with 
FQ orally and parenterally treated weaners [32]. Thus, it remains unclear if the 
source of QNSE in piglets of G1, G2 and G4 were either the piglets’ dams or the 
treated piglets (transmitting QNSE via birth and excretions) or a selective pressure 
made by FQ residues (excreted via milk, urine and feces) in their environment. After 
freezing (- 80°C, swabs stored in tryptic soy broth and glycerol) recovery rate of FQ 
susceptible and resistant E. coli was reported to be good but with a significant 
reduction in number of E. coli at a storage temperature of - 20°C (fecal slurries with 
phosphate buffered saline and glycerol) [46, 47]. In our study native feces was stored 
in stool tubes at - 20°C because of subsequent processing. According to these two 
reports we expect that there was a quantitative reduction of E. coli in our study. The 
mildly selective medium used (Rapid-E. coli 2 agar plates supplemented with 8 mg/L 
nalidixic acid) and picking one isolate of each sample might have distorted our results 




QNSE isolated from fecal samples 
 
QNSE detection rates in fecal samples 
 
The highest QNSE detection rate was found in parenterally and perorally treated pigs 
(G3: 54.2%). Further, it was the group with the highest number of FQ resistant E. coli 
(n = 60) isolated. These results support the opinion that FQ resistance is positively 
associated with previous FQ treatment and can be reduced trough restricted FQ use 
[48-51]. In feces of piglets pertaining to FQ treated dams (G1) QNSE were found. 
From G1 piglets to G1 weaners the QNSE detection rate decreased significantly 
(piglets two- and four-week old: 94.4% and 94.1%, 95% CI: 75.6 - 99.4%, weaners: 
13.3%, 95% CI: 5.7 - 25.5%). Similar results were observed in a French study 
investigating flumequine treated sows and their progeny from various farrow-to-finish 
herds. However, from weaners (age: 60 days, 4.91%) to finishers (age: 150 days, 
1.91%) the percentage of quinolone-resistant E. coli was still decreasing [52]. This is 
in contrast to our study revealing a higher QNSE detection rate in G1 fattening pigs 
(23.8%, 95% CI: 12.9 - 38.2%) compared to G1 weaners (13.3%, 95% CI: 5.7 - 
25.5%) but with overlapping 95% CIs. Apart from G1 similar results were seen in G3, 
G4 and in review of all weaners and fattening pigs (see Table 2). To the author’s 
knowledge, this is the first report describing an increase of QNSE detected in 
fattening pigs. In our study pigs no additional FQ treatments were performed except 
for two weaners which received a second FQ treatment. According to our enquiries, 
the stocks which our study animals were grouped together with in the fattening units 
previously had received FQ treatment on the breeding farm. Thus, we assume that 
pigs from these stocks might have also spread QNSE and the herd mixing could 
have led to this increase leaving more QNSE positive study pigs. Interspecies 
transfer of nalidixic acid resistant E. coli in chickens and cattle was published before 
[53, 54]. Furthermore, there is a risk for transferring resistant bacteria between 
countries via purchase of animals. For example, in chickens international transfer of 
colistin-resistant E. coli was reported [20]. No significant differences between study 
groups could be observed at a specific sampling time (i.e. at the four different ages 
from farrowing to fattening unit). This was rather surprising to us assuming that 
different FQ backgrounds (treated vs. contact vs. control animals) would lead to 
different detection rates. The relatively low number of sampled pigs per group and 
age might have concealed this effect and could be rechecked by larger group 
designs. Irrelevant of age control pigs were tested positive for QNSE but the 
detection rate (G5, 7.8%, 95% CI: 3.5 - 14.7%) was significantly lower compared to 
pigs of other groups (G1-G4, 36.9 - 54.2%, 95% CI: 28.3 - 62.2%). All seven QNSE 
isolates (7/90, 7.8%) in the control group originated from pigs of the same farm 
reporting the last FQ treatment to be three months ago (last treatment: July 2017, 
sampling: October 2017). In the other control farms no QNSE were found and the 
last FQ treatment was reported between 30 and 34 months before sampling. This is 
in contrast to a Swedish and English study finding quinolone resistant bacteria 
isolated in swine without any prehistory of FQ use. The latter study described that, 
beside reducing antimicrobial use to a minimum, biosecurity, e.g. purchase of 
animals, surrounding animal farms and farm hygiene, is an important factor in the 
existence and spread of antimicrobial resistant microbes [55, 56]. Although results 
must be compared with caution because of different material and methods 
performed, QNSE detection rates in our piglets were markedly higher (G1-G4, 72.5 - 
100.0%) compared to Belloc et al. (2005) (percentage of quinolone-resistant E. coli at 
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7 and 30 days of age: 14.0 and 14.7%) [52]. The gastrointestinal tract of newborns is 
first colonized by the mother’s vaginal flora and microbes of their environment. The 
shift from liquid to solid feed and increasing age lead to an alternation of colonizing 
microbes [57, 58]. Neonatal antibiotic treatment was reported to have a negative 
influence on the microbial diversity. It decreases the abundance of protective 
commensal bacteria which promotes the colonization of antibiotic resistant bacteria 
[59]. These aspects might explain the high detection rates of QNSE in our study 
piglets and the significant reduction in weaners. QNSE were detected in both contact 
groups (G2 and G4) from piglets to fattening pigs having in- or direct contact to G1 - 
and G3 - pigs. Furthermore, at any age the detection rates in contact animals (G2 
and G4, Table 2) were sometimes equal or larger compared to treated pigs (G1 and 
G3, Table 2). Despite the small number of study animals (n = 15) and a different 
indicator bacterial species (Campylobacter) used, comparable detection rates of FQ 
resistant Campylobacter in contact animals were discovered in a Japanese study. 
After three days of group housing all five contact pigs previously being negative 
(grouped together with one previously with 5 mg/kg enrofloxacin intramuscularly 
treated pig which was tested positive for FQ resistant Campylobacter) were colonized 
by FQ resistant Campylobacter [60]. This is in contrast to a German experimental 
trial where four ciprofloxacin-resistant E. coli isolates (defined as above the 
epidemiological cut-off value: MIC > 0.06ug/ml) were detected in each treated and 
contact group but 47 ciprofloxacin-resistant E. coli isolates in the control group. 
Possible factors that could explain the low detection rate in treated and contact 
animals in the study described are the experimental environment conditions (free of 
ciprofloxacin-resistant E. coli), choice of study animals (single breeding unit, no 
antimicrobial use in dams and piglets before), high hygiene and biosecurity standards 
during the study and small group sizes. Contact animals either get colonized by FQ 
resistant bacteria by oral uptake via feces and urine or antibiotic residues in 
excretions which exert a selection for FQ resistant bacteria [32]. Separation of 
diseased animals and proper hygiene levels are keys to promote healing and prevent 
infectious diseases from spreading in the animal stock [61]. According to the results 
above this measurement is also advisable to reduce the risk of transferring resistant 
bacteria or exposing animals and human beings to antibiotic residues. Seven out of 
19 fattening pigs (36.8%) were positive for QNSE after oral treatment with FQ as 
suckling piglet compared to one out of 8 fattening pigs (12.5%) tested positive for 
QNSE after intramuscular treatment as suckling piglet. Due to a low power we 
forewent carrying out any further statistical evaluation of the route of applications 
(i.m. and p.o.) used in this study. However, previous investigation reported resistance 
rates to be independent of the route of administration [62, 63]. More studies with 
larger sample sizes are needed.  
 
Counts of QNSE per gram feces 
 
In the current literature several studies describe quantitative analyses with 
commensal E. coli before, during and after treatment to assess the antibiotic’s 
influence on the gut flora. These studies agree that during and shortly after treatment 
there is a decrease of E. coli but with a recolonization within days or weeks [31, 52, 
60, 63, 64]. In our study, with increasing age of the pigs we detected continuously 
decreasing mean and median counts of QNSE per gram feces. In fact, the content of 
QNSE decreased by a factor of almost 105 between two-week old piglets (mean of 
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G3: 7.1 log CFU/g feces) and fattening pigs (mean of G3: 2.2 log CFU/g feces). 
Samples from two-week old piglets of G1 and G3 (mean of G1: 7.0 log CFU/g feces, 
mean of G3: 7.1 log CFU/g feces) showed the highest counts which met our 
expectations because they were either FQ treated piglets or piglets of FQ treated 
sows. Treated pigs were shown before to have higher counts per gram feces 
dependent on dosing than placebo pigs [65]. This could explain why counts of G1 
(piglets of treated sows) were lower compared to G3 expecting to have received a 
lower dose of FQ via milk than treated piglets. Nonetheless, we were surprised by 
the number of QNSE detected in these samples with the treatment of piglets and 
sows being about ten to 14 days ago. In a study measuring FQ resistant 
Campylobacter in weaners (age: 18 days) during and after FQ administration similar 
amounts (105 to 107 colony forming units per gram feces) were found five days post 
treatment [60]. In our study counts in samples from four-week old piglets decreased 
compared to samples of two-week old piglets but were tenfold higher in piglets of 
treated sows (G1) and contact piglets (G2) (mean of G1: 6.4 log CFU/g feces, mean 
of G2: 6.4 log CFU/g feces) compared to treated piglets (G3) and contact piglets (G4) 
(mean of G3: 5.4 log CFU/g feces, mean of G4: 5.1 log CFU/g feces). The amount of 
FQ used are dosed according to the animal’s bodyweight. Consequently, in farms 
with FQ treatment in sows larger amounts of FQ were used. This could lead to a 
larger amount of antibiotic residues in milk, feces and the environment which could 
explain these high counts in four-week old piglets. In sows independent of FQ 
treatment QNSE were detected shortly after entry into the farrowing units and before 
farrowing by Stohler et al. (2019) [44]. In a Swedish study successful vertical 
transmission of quinolone resistant E. coli was described in broiler production by 
introducing positive breeding birds [45]. In a recent study piglets of dams with 
detection of ampicillin or azithromycin resistance had a higher chance of being 
positive for these resistances [62]. This means that transmission of QNSE from 
positive sows to their progeny could possibly explain the high detection rates in 
piglets of G1 (treated piglets) and G2 (contact piglets). Another interesting 
observation were the means of QNSE detected in contact weaners (G2: 3.1 log 
CFU/g feces, G4: 3.4 log CFU/g feces) being ten- to a hundredfold higher than in 
treated weaners (G1: 2.3 log CFU/g feces, G3: 1.0 log CFU/g feces). In the count 
part of the hurdle model contact weaners (Ctat) had significantly higher counts (Ctat; 
3.757 log CFU/g feces, 95% CI: 3.754 - 3.760) compared to treated weaners (Trt; 
1.888 log CFU/g feces, 95% CI: 1.877 - 1.899). A similar outcome was observed 
when one weaner being positive for FQ resistant Campylobacter after enrofloxacin 
treatment was grouped together with five negative weaners. After five days in four of 
five weaners same or higher amounts of FQ resistant Campylobacter were detected 
[60]. These results lead to the assumption that QNSE could maintain and remain 
easier in the intestinal floras of contact weaners than in those of treated weaners. 
The intake of antibiotic residues and therefore the exposure of the intestinal flora to 
low-dose antibiotic amounts could promote development of resistant bacteria or 
exchange of antimicrobial resistance genes between bacteria in contact animals. 
From the qualitative view our results and the results of Burow et al. (2019) suggest 
that treated animals are more likely to harbor antibiotic resistant bacteria than not 
treated animals [62]. But in terms of quantity, contact weaners could harbor more 
antibiotic resistant bacteria than treated weaners. Either in weaners or fattening pigs, 
the results of the hurdle model showed significantly lower counts in control animals 
(Ctrl weaner; 1.707 log CFU/g feces, 95% CI: 1.689 - 1.725, Ctrl fattening pig; 1.936 
log CFU/g feces, 95% CI: 1.922 - 1.949) compared to treated (Trt weaner; 1.888 log 
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CFU/g feces, 95% CI: 1.877 - 1.899, Trt fattening pigs; 3.378 log CFU/g feces, 95% 
CI: 3.373 - 3.383) and contact animals (Ctat weaner; 3.757 log CFU/g feces, 95% CI: 
3.754 - 3.760, Ctat fattening pig; 2.800 log CFU/g feces, 95% CI: 2.791 - 2.809). This 
is in agreement with other investigations with the exception that all control animals 
were negatively tested for resistant bacteria. An explanation for this finding may be 
the already mentioned fact, that our study was carried out under field conditions with 
lower hygienic standards compared to the other experimental studies. Detections 
rates of weaners were insignificantly lower than those in fattening pigs. Furthermore, 
no significance was found in the zero part of the hurdle model within the groups (Trt, 
Ctat and Ctrl) and between weaners and fattening pigs. However, the count part of 
the hurdle model showed that there is a significant difference in counts of QNSE 
between weaners and fattening pigs and between all three groups (view Table 3). As 
described above along with the environment and the additional FQ treatment, which 
can be ruled out, purchase and integration of pigs with possible FQ contact can 
reincrease the quantity of QNSE excreted per pig due to horizontal transfer of QNSE 
or antibiotic residues. Pigs which have not been treated or not being in contact with 
FQ treated pigs might have the lowest or no excretions of QNSE which can be 
confirmed by four other surveys [56, 60, 64, 66] but one study describing 
contradictory results [32].  
 
MIC of QNSE isolated from feces 
 
Looking at the distribution of ciprofloxacin resistant E.coli strains (120/254, 47.2%), 
most of them were found in pigs which were part of G3 (treated pigs, 60/120, 50.0%) 
and G4 (contact pigs, 36/120, 30.0%), followed by pigs of G1 (treated pigs, 12/120, 
10.0%), G2 (contact pigs, 11/120, 9.2%) and G5 (control pigs, 1/120, 0.8%). 
Resistance proportions significantly differed between G3 (S: 23.1%, 95% CI 15.1 - 
33.6%, R: 79.6%, 95% CI: 66.4 - 84.9%) and G1, G2, G4 and G5 (S: 53.2 - 71.4%, 
95% CI: 35.9 - 91.8%, R: 14.3 - 45.6%, 95% CI: 2.6 - 56.5%, view Table 6). This 
meets the results of Römer et al. (2017) comparing E. coli growth on enrofloxacin 
supplemented agar plates between an experimental and control group although MIC 
values of the two groups did not differ significantly [31]. Seven days after enrofloxacin 
treatment they found the first non-wildtype-E. coli (MIC-values above ECOFF). Due 
to our study protocol we are not able to chronologically describe the first detection of 
QNSE or FQ resistant E. coli. In the study of Römer et al. (2017) the experimental 
group was held in the same room with the control group which was tested positive for 
non-wildtype-E. coli (agar with 0.125 mg/L enrofloxacin) only after the second 
treatment at day 28 and for enrofloxacin-resistant E. coli (agar with 4mg/L 
enrofloxacin) at day 42 [31]. On the contrary, we found QNSE and FQ resistant E. 
coli in both treated and contact piglets (held in the same room or litter) at the first 
sampling day (two-weeks of age) and again at four-weeks of age (second sampling 
day). This emphasizes that transmission may be faster under field conditions, e.g. by 
higher animal density, compared to laboratory standards. Wild-type E. coli 
susceptible to ciprofloxacin were only found before FQ treatment [31]. During our 
study there was only one QNSE strain with a MIC value below the ECOFF detected 
which belonged to a weaner of G1, i.e. approximately nine weeks after FQ treatment. 
By Römer et al. (2017) highest MICCIP values (6 - 32 mg/L) were measured three to 
five weeks (day 42 and day 54) after a second treatment of FQ. Highly ciprofloxacin 
resistant strains were detected in almost all age and croup categories of our trial but 
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most of them were collected from two- and four-week old piglets being sampled 
around one to three weeks after their treatment [31]. Similar peak times were 
observed by Delsol et al. (2004) and Belloc et al. (2005) [52, 64]. In the study of 
Burow et al. (2018) detection times were different. First ciprofloxacin non-wildtype 
E.coli isolates were detected at day 56 (app. seven weeks after treatment) in orally 
treated pigs and their contact pigs [32]. Surprisingly, control animals were tested 
positive much earlier during treatment days (day 1) up to 42 days after treatment. 
However, highest MIC values of ciprofloxacin did not exceed 2 µg/ml in the described 
study. Observing ciprofloxacin’s MIC 50% and MIC 90%, we noticed some gradual 
decreases with age in all five groups. Huang et al. (2014) also showed a decrease in 
the average MICs of experimental pigs from day 30 (stopping the oral treatment) until 
day 60 [48]. Control pigs did not exceed an average MIC of 1 µg/ml. Without any 
further drug selection pressure improving fitness may take over a more important role 
in bacteria. In vitro FQ resistant Salmonellae showed prolonged generation times and 
disability to maintain in the gut flora of chickens compared to wildtype strains. 
Without antibiotic selection pressure in vitro and in vivo fitness costs reversed leading 
to a slight decrease in FQ resistance [67]. However, there exist fitness-compensatory 
mutations and additional resistance mutations which can improve the fitness and 
therefore maintain or increase the level of minimal inhibitory concentration [68]. Apart 
from initial FQ treatment in our study no additional FQ treatment was performed 
except for two weaners. In the absence of further FQ selection pressure and further 
fitness improvements these factors might explain some gradual decreases of MICs 
with increasing age category. In weaners of G2 (S = 100.0%, 95% CI = 66.9 - 
100.0%, R = 0.0%, 95% CI = 0.0 - 33.1%) and G3 (S = 0.0%, 95% CI = 0.0 - 44.5%, 
R = 100.0%, 95% CI = 55.5 - 100.0%, view Table 8) ciprofloxacin susceptibility 
proportions differed significantly. In groups of Trt and Ctrl this was not reproducible. 
Treated pigs having a higher risk of carrying ciprofloxacin resistant strains met our 
expectations due to the current literature [31, 51, 62, 65, 69]. Further, we would have 
expected G5 to have significantly different susceptibility proportions compared to G1 
to G4. The low number of strains isolated in the different groups of weaners and 
fattening pigs might have made it impossible to observe such a difference. Other 
studies with more strains per group are needed to test differences in susceptibility 
proportions. Being part of a SPS seems to inherit a higher risk of having FQ resistant 
strains in fattening pigs compared to fattening pigs originating from farms not 
connected to a SPS. As mentioned before sows carried QNSE and FQ resistant E. 
coli which were sampled shortly after entry into the farrowing unit and before the FQ 
treatment [44, 52]. This means that the transmission of QNSE and FQ resistant E. 
coli is promoted by a system of moving sows from one unit to another. In the current 
literature we did not find any comparable studies which investigated the occurrence 
of bacterial resistances in pigs of SPS and without SPS connection. 
 
QNSE isolated from environmental samples 
 
QNSE detection rates in environmental samples 
 
Of all 179 environmental samples 25 (14.0%) were tested positive for QNSE. Most of 
the positive samples were floor and wall wipes (15/63, 23.8%), followed by slurry 
samples (9/49, 18.4%) and one dust sample (1/67, 1.5%). FQ treatment was 
performed in the farrowing units where in one third of the environmental samples 
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(10/34, 29.4%) QNSE were observed. A recently published study in Switzerland used 
similar sampling and laboratory techniques and revealed much higher proportions of 
environmental samples (pen wall samples: 51.9%, liquid manure: 70.4% and dust: 
45.2%) being positive for quinolone resistant E. coli. Farrowing to rearing farms were 
also affected the most besides a much higher detection rate (25/26, 96.2%) [70]. The 
influence of season was investigated before with contradictory outcomes concerning 
its effect [56, 71, 72]. Further, weather conditions, e.g. rain causing a dilution effect, 
could have had an influence by causing a lower detection rate in slurry samples. It 
was rather surprising to us that in this experimental trial only 1 of 67 dust samples 
maximally stored for half a year contained QNSE. In comparison, a German study 
detected FQ resistant E. coli in 54 of 119 dust samples of which some were more 
than 20 years old. Different sampling and store conditions might explain this disparity 
[24]. Besides the animals themselves, farmers and veterinarians spend a lot of time 
in barns where they can inhale dust or dust can be released into the environment by 
ventilation systems [73]. More investigation is needed to evaluate the level of risk for 
transferring QNSE via farm dust. In almost one fifth of the slurry samples QNSE were 
detected (9/49, 18.4%). Farmers fertilize their crop fields using liquid manure. In 
recent years a lot of research was invested in this upcoming topic revealing antibiotic 
residues and antibiotic resistance genes are distributed bearing the risk of 
contaminating harvest production for livestock and human beings [20-24]. To reduce 
or eliminate pathogenic and antibiotic resistant bacteria in the livestock’s environment 
cleaning and disinfection are crucial [61, 74]. This differed widely having fattening 
units which have never cleaned and disinfected their pens and fattening units with a 
good cleaning and disinfection plan after every emptying. Out of the three floor and 
wall wipes being positive for QNSE two originated from fattening farms performing 
cleaning on a regular basis but without disinfection afterwards. This emphasizes the 
need of cleaning and disinfection and practicing it correctly. After all, only a reduction 
of bacteria can be achieved and not a complete elimination. 
 
Number of QNSE in environmental samples 
 
In the semiquantitative approach of slurry samples on average 2.8 log CFU/ml were 
detected. In dust and floor and wall wipes the average count was 3.0 log CFU/g and 
2.8 log CFU/g, respectively. In disagreement with the survey of von Ah et al. (2019) 
counts of quinolone-resistant colonies were the highest in slurry samples (11’831 
CFU/ml = 4.1 log CFU/ml) followed by dust (111 CFU/g = 2.0 log CFU/ml) and pen 
wall samples (40 CFU/g = 1.6 log CFU/g) [70]. Similar to fecal samples highest 
counts of environmental samples were detected in the farrowing units (3.1 and 3.7 
log CFU/g). This underlines that the highest detection rate and count of QNSE must 
be clearly linked to institutions where FQ treatment is performed because the chance 
of finding FQ residues is high [73]. Nevertheless, QNSE were detected in the 
fattening units’ environment but from this set of data we cannot determine the source 
of QNSE. 
 
MIC of QNSE in environmental samples 
 
MIC distribution of nalidixic acid and ciprofloxacin were most favourable in dust but 
only one strain was detected which limits the significance of this information (view 
Table 10). This is in contrast to the studies of Schulz et al. (2016) and Römer et al. 
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(2017) in which they observed growth of E. coli on plates supplemented with 2 µg/ml 
ciprofloxacin and 4 µg/ml enrofloxacin, respectively [24, 31]. MIC 50% of wipe 
samples (4 ug/ml) was higher compared to MIC 50% of slurry samples (0.19 ug/ml). 
From these results we could assume that MIC distribution might be more favourable 
in slurry than in floor and wall wipes. Nevertheless, only few strains were detected in 
environmental samples leaving wide and overlapping confidence intervals in 
resistance proportions between dust, floor and wall wipes and slurry. Comparing 
MICs of fecal samples with the MICs of environmental samples we observed a 
slightly better resistance situation in environmental samples (FQ resistant E. coli in 
environmental samples: 36.0%, 95% CI: 20.2 - 55.5%, FQ resistant E. coli in fecal 
samples: 47.2%, 95% CI: 41.2 - 53.4%) but with overlapping 95% CIs. Studies 




In this study we compared farms with a regular FQ usage and farms without any FQ 
usage for the past three to 34 months. For future research it would be of interest to 
compare farms using low and high amounts of FQ with farms which have never used 
FQ before. Furthermore, the total number of FQ treatments and FQ treated pigs per 
farm should be included into the study protocol for evaluation which of these two 
factors would be of more influence in FQ resistance situation. This information could 
be useful for future consulting of pig farm management. These aspects were 
investigated before concerning tetracycline resistance which had an effect on the 
probability of detecting resistant isolates [75]. FQs have been reported to promote 
the selection of resistances against other antibiotics in E. coli and Campylobacter coli 
[32, 64, 76]. Thus, a more extensive testing for other antibiotic resistances would be 
beneficial to see if besides FQ resistances other selection processes are promoted. 
For further studies measurements of FQ residues and genetic background of 
detected strains would be helpful to gain information about origin and spread of 
individual E. coli strains [31, 32]. Additionally, sampling the environment before the 
entry of animals and sampling piglets before any treatment could rule out preexisting 







In this study we investigated the presence of QNSE in pigs treated with FQs, pigs 
from FQ treated sows, pigs being in indirect or direct contact with the pigs mentioned 
before and pigs from farms where FQs have not been used for several months or 
years. Additionally, the environment around the pigs was screened. Two-hundred 
and fifty-four of 621 fecal samples were tested positive for QNSE (40.9%). According 
to age most of the QNSE-positive samples were found in two- (109/116, 94.0%) and 
four-week old piglets (88/104, 85.6%). QNSE were also present in fecal samples of 
pigs originating from farms which stopped FQ use months or years ago (7/90, 7.8%). 
The detection rate (G1, G2, G3, and G4 vs. G5) and counts of QNSE (Trt and Ctat 
vs. Ctrl) were significantly lower in control pigs compared to treated and contact pigs. 
Almost half of the isolated QNSE-strains (126/254, 49.6%) were intermediate or 
resistant to ciprofloxacin (≥ 3 µg/ml ciprofloxacin respectively). Fattening pigs of SPS-
farms showed a significantly higher ciprofloxacin resistance rate compared to 
fattening pigs of non-SPS-farms. In the environment 14.0% of samples (25/179) 
contained QNSE of which most were isolated of floor and wall wipes. Quantitatively 
most QNSE were present in the farrowing units. 40.0% (10/25) of the isolates were 
either intermediate or resistant to ciprofloxacin. From these results we can clearly 
see that FQ resistant bacteria in pigs are associated with FQ use in farrowing units 
but that there are no boarders to FQ resistant bacteria when it comes to contact 
animals and the environment. Further, restricted or non-use of FQs is not the only act 
it needs to minimize or eliminate FQ resistant bacteria in pig farming. Further 
research in the spread of FQ resistant bacteria and its promoting factors are 
necessary. Adapting a special management of antibiotically treated pigs in farms, 
restricted transport and purchase are also of concern. Especially in the environment, 
e.g. farm dust and slurry, new approaches are needed to reduce the contamination 
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Isolate Sample Unit SPS Group QNSE CFU/g or ml QNSE log CFU/g or ml MICNA MICCIP 
1 Fecal Farrowing + 1 32’000’000 7.5  256  0.125 
2 Fecal Farrowing + 1 42’000’000 7.6  256  0.125 
3 Fecal Farrowing + 1 1’330’000 6.1  96  0.094 
4 Fecal Farrowing + 1 970’000 6.0  >256  >32 
5 Fecal Farrowing + 1 10’480’000 7.0  >256  >32 
6 Fecal Farrowing + 1 14’880’000 7.2  256  0.125 
7 Fecal Farrowing + 1 4’180’000 6.6  256  0.125 
8 Fecal Farrowing + 1 4’420’000 6.6  256  0.19 
9 Fecal Farrowing + 1 680’000 5.8  128  0.125 
10 Fecal Farrowing + 1 3’160’000 6.5  256  0.19 
11 Fecal Farrowing + 1 28’800’000 7.5  96  0.125 
12 Fecal Farrowing + 1 6’130’000 6.8  192  0.125 
13 Fecal Farrowing + 1 16’160’000 7.2  128  0.125 
14 Fecal Farrowing + 1 180’000 5.3  >256  3 
15 Fecal Farrowing + 1 2’000’000 6.3  96  0.125 
16 Fecal Farrowing + 1 3’440’000 6.5  96  0.125 
17 Fecal Farrowing + 1 21’680’000 7.3  128  0.125 
18 Fecal Farrowing + 2 85’000 4.9  >256  6 
19 Fecal Farrowing + 2 1’500’000 6.2  256  0.19 
20 Fecal Farrowing + 2 70’000 4.8  256  0.125 
21 Fecal Farrowing + 2 1’000 3.0  >256  >32 
22 Fecal Farrowing - 2 47’000 4.7  128  0.125 
23 Fecal Farrowing + 2 1’000 3.0  256  0.125 
24 Fecal Farrowing + 2 3’940’000 6.6  96  0.094 
25 Fecal Farrowing + 2 450’000 5.7  >256  >32 
26 Fecal Farrowing + 2 23’280’000 7.4  >256  >32 
27 Fecal Farrowing + 2 260’000 5.4  192  0.125 
28 Fecal Farrowing + 2 220’000 5.3  >256  4 
29 Fecal Farrowing + 2 3’220’000 6.5  128  0.125 
30 Fecal Farrowing + 2 24’000’000 7.4  96  0.125 
31 Fecal Farrowing + 2 87’000 4.9  >256  4 
32 Fecal Farrowing + 2 4’880’000 6.7  64  0.094 
33 Fecal Farrowing + 2 720’000 5.9  192  0.19 
34 Fecal Farrowing + 2 1’380’000 6.1  192  0.125 
35 Fecal Farrowing + 2 35’000’000 7.5  >256  3 
36 Fecal Farrowing + 3 35’000 4.5  >256  8 
37 Fecal Farrowing + 3 900 3.0  24  0.125 
38 Fecal Farrowing + 3 43’200’000 7.6  >256  8 
39 Fecal Farrowing + 3 1’556’000 6.2  >256  >32 
40 Fecal Farrowing + 3 100’000 5.0  >256  8 
41 Fecal Farrowing + 3 72’800’000 7.9  >256  8 
42 Fecal Farrowing + 3 3’700’000 6.6  >256  >32 
43 Fecal Farrowing + 3 7’000 3.8  >256  >32 
44 Fecal Farrowing + 3 1’000’000 6.0  >256  8 
45 Fecal Farrowing + 3 700’000 5.8  >256  >32 
46 Fecal Farrowing + 3 1’000’000 6.0  >256  8 
47 Fecal Farrowing + 3 5’500’000 6.7  >256  >32 
48 Fecal Farrowing + 3 1’400’000 6.1  >256  >32 
49 Fecal Farrowing + 3 194’400’000 8.3  >256  >32 
50 Fecal Farrowing + 3 29’700’000 7.5  >256  8 
51 Fecal Farrowing - 3 1’600’000 6.2  >256  32 
52 Fecal Farrowing - 3 16’600’000 7.2  >256  >32 
53 Fecal Farrowing - 3 7’440’000 6.9  >256  24 
54 Fecal Farrowing - 3 12’300’000 7.1  >256  32 
55 Fecal Farrowing - 3 6’000 3.8  >256  32 
56 Fecal Farrowing - 3 4’000 3.6  >256  32 
57 Fecal Farrowing - 3 33’200’000 7.5  >256  24 
58 Fecal Farrowing - 3 34’400’000 7.5  >256  32 
59 Fecal Farrowing - 3 5’400’000 6.7  >256  32 
60 Fecal Farrowing - 3 62’400’000 7.8  >256  32 
61 Fecal Farrowing - 3 1’000’000 6.0  >256  8 
62 Fecal Farrowing - 3 3’500’000 6.5  >256  6 
63 Fecal Farrowing - 3 60’000 4.8  >256  8 
64 Fecal Farrowing - 3 100’000 5.0  >256  6 
65 Fecal Farrowing - 3 100’000 5.0  >256  4 
66 Fecal Farrowing - 3 200’000 5.3  256  0.125 
67 Fecal Farrowing - 3 140’000 5.1  >256  6 
68 Fecal Farrowing - 3 800’000 5.9  >256  6 
69 Fecal Farrowing - 3 100’000 5.0  >256  >32 
70 Fecal Farrowing - 3 40’000 4.6  >256  >32 
71 Fecal Farrowing - 3 50’000 4.7  >256  8 
72 Fecal Farrowing - 3 20’000 4.3  >256  >32 
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73 Fecal Farrowing + 4 1’900’000 6.3  >256  8 
74 Fecal Farrowing + 4 1’870’000 6.3  256  0.19 
75 Fecal Farrowing + 4 30’000 4.5  >256  6 
76 Fecal Farrowing + 4 8’000 3.9  64  0.19 
77 Fecal Farrowing + 4 2’000 3.3  256  0.19 
78 Fecal Farrowing + 4 1’380’000 6.1  256  0.19 
79 Fecal Farrowing + 4 90’000 5.0  >256  >32 
80 Fecal Farrowing + 4 60’000 4.8  >256  0.38 
81 Fecal Farrowing + 4 3’000 3.5  >256  0.38 
82 Fecal Farrowing + 4 30’000 4.5  >256  >32 
83 Fecal Farrowing + 4 5’240’000 6.7  >256  >32 
84 Fecal Farrowing + 4 1’090’000 6.0  >256  >32 
85 Fecal Farrowing + 4 4’100’000 6.6  >256  >32 
86 Fecal Farrowing + 4 740’000 5.9  >256  8 
87 Fecal Farrowing + 4 60’000 4.8  >256  >32 
88 Fecal Farrowing - 4 40’000 4.6  256  0.094 
89 Fecal Farrowing - 4 6’080’000 6.8  256  0.19 
90 Fecal Farrowing - 4 1’440’000 6.2  256  0.19 
91 Fecal Farrowing - 4 110’000 5.0  256  0.125 
92 Fecal Farrowing - 4 20’000 4.3  256  0.094 
93 Fecal Farrowing - 4 100’000 5.0  256  0.094 
94 Fecal Farrowing - 4 800’000 5.9  256  0.094 
95 Fecal Farrowing - 4 30’000 4.5  >256  >32 
96 Fecal Farrowing - 4 20’000 4.3  >256  0.094 
97 Fecal Farrowing - 4 500’000 5.7  256  0.125 
98 Fecal Farrowing - 4 430’000 5.6  256  0.19 
99 Fecal Farrowing - 4 2’000 3.3  256  0.125 
100 Fecal Farrowing - 4 25’000 4.4  >256  12 
101 Fecal Farrowing - 4 330’000 5.5  256  0.125 
102 Fecal Farrowing - 4 1’000 3.0  256  0.125 
103 Fecal Farrowing - 4 40’000 4.6  >256  >32 
104 Fecal Farrowing - 4 25’000 4.4  >256  8 
105 Fecal Farrowing - 4 30’000 4.5  256  0.19 
106 Fecal Farrowing - 4 6’000 3.8  >256  6 
107 Fecal Farrowing - 4 7’000 3.8  >256  >32 
108 Fecal Farrowing - 4 440’000 5.6  >256  >32 
109 Fecal Farrowing - 4 40’000 4.6  >256  8 
110 Fecal Farrowing + 1 240’000 5.4  192  0.094 
111 Fecal Farrowing + 1 9’000 4.0  >256  0.125 
112 Fecal Farrowing + 1 220’000 5.3  >256  4 
113 Fecal Farrowing - 1 56’000 4.7  24  0.19 
114 Fecal Farrowing + 1 6’880’000 6.8  192  0.094 
115 Fecal Farrowing + 1 3’220’000 6.5  >256  32 
116 Fecal Farrowing + 1 1’480’000 6.2  192  8 
117 Fecal Farrowing + 1 61’000 4.8  >256  0.125 
118 Fecal Farrowing + 1 15’000’000 7.2  >256  >32 
119 Fecal Farrowing + 1 11’000 4.0  >256  3 
120 Fecal Farrowing + 1 3’440’000 6.5  96  0.094 
121 Fecal Farrowing + 1 119’000 5.3  256  0.125 
122 Fecal Farrowing + 1 89’000 4.9  >256  6 
123 Fecal Farrowing + 1 12’440’000 7.1  192  0.094 
124 Fecal Farrowing + 1 22’000 4.3  >256  3 
125 Fecal Farrowing + 1 60’000 4.8  >256  0.125 
126 Fecal Farrowing + 2 830’000 5.9  256  0.125 
127 Fecal Farrowing + 2 2’240’000 6.4  >256  0.094 
128 Fecal Farrowing + 2 3’840’000 6.6  96  0.094 
129 Fecal Farrowing + 2 500 2.7  >256  4 
130 Fecal Farrowing + 2 5’780’000 6.8  192  0.094 
131 Fecal Farrowing + 2 3’520’000 6.5  >256  32 
132 Fecal Farrowing + 2 4’000 3.6  128  0.125 
133 Fecal Farrowing + 2 4’240’000 6.6  128  0.094 
134 Fecal Farrowing + 2 5’120’000 6.7  >256  32 
135 Fecal Farrowing + 2 250’000 5.4  96  0.094 
136 Fecal Farrowing + 2 1’450’000 6.2  24  0.25 
137 Fecal Farrowing + 3 1’000’000 6.0  >256  0.19 
138 Fecal Farrowing + 3 2’976’000 6.5  >256  8 
139 Fecal Farrowing + 3 200 2.3  >256  >32 
140 Fecal Farrowing + 3 7’000 3.8  >256  6 
141 Fecal Farrowing + 3 224’000 5.4  48  0.19 
142 Fecal Farrowing + 3 74’000 4.9  >256  6 
143 Fecal Farrowing + 3 62’000 4.8  256  0.19 
144 Fecal Farrowing + 3 480’000 5.7  256  0.19 
145 Fecal Farrowing + 3 14’000 4.1  >256  9 
146 Fecal Farrowing + 3 59’000 4.8  >256  >32 
147 Fecal Farrowing + 3 1’000’000 6.0  256  0.19 
148 Fecal Farrowing + 3 1’000’000 6.0  >256  0.19 
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149 Fecal Farrowing + 3 3’000 3.5  >256  >32 
150 Fecal Farrowing + 3 1’000’000 6.0  >256  6 
151 Fecal Farrowing - 3 300 2.5  256  0.125 
152 Fecal Farrowing - 3 200 2.3  >256  6 
153 Fecal Farrowing - 3 3’700 3.6  >256  6 
154 Fecal Farrowing - 3 69’000 4.8  >256  6 
155 Fecal Farrowing - 3 23’000 4.4  >256  6 
156 Fecal Farrowing - 3 30’000 4.5  >256  6 
157 Fecal Farrowing - 3 4’000 3.6  >256  6 
158 Fecal Farrowing - 3 11’000 4.0  >256  6 
159 Fecal Farrowing - 3 5’000 3.7  >256  6 
160 Fecal Farrowing - 3 784’000 5.9  >256  6 
161 Fecal Farrowing - 3 2’180’000 6.3  >256  6 
162 Fecal Farrowing - 3 33’000 4.5  >256  0.125 
163 Fecal Farrowing - 3 100 2.0  256  >32 
164 Fecal Farrowing - 3 800 2.9  >256  6 
165 Fecal Farrowing - 3 22’000 4.3  >256  6 
166 Fecal Farrowing + 4 269’000 5.4  >256  6 
167 Fecal Farrowing + 4 55’000 4.7  >256  6 
168 Fecal Farrowing + 4 1’000 3.0  >256  3 
169 Fecal Farrowing + 4 201’000 5.3  >256  6 
170 Fecal Farrowing + 4 21’000 4.3  >256  6 
171 Fecal Farrowing + 4 427’000 5.6  >256  6 
172 Fecal Farrowing + 4 2’000 3.3  >256  0.125 
173 Fecal Farrowing + 4 6’000 3.8  >256  6 
174 Fecal Farrowing + 4 5’000 3.7  >256  6 
175 Fecal Farrowing + 4 1’628’000 6.2  >256  >32 
176 Fecal Farrowing + 4 741’000 5.9  >256  >32 
177 Fecal Farrowing + 4 496’000 5.7  >256  0.25 
178 Fecal Farrowing - 4 57’000 4.8  >256  >32 
179 Fecal Farrowing - 4 19’000 4.3  256  0.19 
180 Fecal Farrowing - 4 50’000 4.7  256  0.125 
181 Fecal Farrowing - 4 4’000 3.6  256  0.125 
182 Fecal Farrowing - 4 18’000 4.3  256  0.19 
183 Fecal Farrowing - 4 1’000 3.0  256  0.125 
184 Fecal Farrowing - 4 400 2.6  256  0.19 
185 Fecal Farrowing - 4 1’000 3.0  256  0.125 
186 Fecal Farrowing - 4 400 2.6  256  0.19 
187 Fecal Farrowing - 4 200 2.3  256  0.125 
188 Fecal Farrowing - 4 14’000 4.1  256  0.19 
189 Fecal Farrowing - 4 31’000 4.5  >256  6 
190 Fecal Farrowing - 4 30’000 4.5  >256  6 
191 Fecal Farrowing - 4 2’000 3.3  >256  6 
192 Fecal Farrowing - 4 2’800 3.4  >256  6 
193 Fecal Farrowing - 4 6’000 3.8  >256  6 
194 Fecal Farrowing - 4 100 2.0  256  0.125 
195 Fecal Farrowing - 4 200 2.3  >256  6 
196 Fecal Farrowing - 4 148’000 5.2  >256  6 
197 Fecal Farrowing - 4 317’000 5.5  >256  6 
198 Fecal Rearing - 1 100 2.0  >256  0.19 
199 Fecal Rearing + 1 4’500 3.7  256  0.125 
200 Fecal Rearing + 1 300 2.5  24  0.047 
201 Fecal Rearing + 1 100 2.0  >256  6 
202 Fecal Rearing + 1 100 2.0  >256  4 
203 Fecal Rearing + 1 4’400 3.6  >256  0.125 
204 Fecal Rearing + 2 400 2.6  256  0.19 
205 Fecal Rearing - 2 400 2.6  256  0.19 
206 Fecal Rearing + 2 4’700 3.7  192  0.125 
207 Fecal Rearing + 2 100 2.0  256  0.125 
208 Fecal Rearing + 2 1’300 3.1  256  0.125 
209 Fecal Rearing + 2 39’600 4.6  192  0.125 
210 Fecal Rearing + 3 100 2.0  >256  >32 
211 Fecal Rearing + 3 100 2.0  >256  6 
212 Fecal Rearing - 3 100 2.0  >256  >32 
213 Fecal Rearing - 3 100 2.0  >256  32 
214 Fecal Rearing + 4 100’000 5.0  >256  6 
215 Fecal Rearing - 5 100 2.0  >256  3 
216 Fecal Rearing - 5 800 2.9  256  0.125 
217 Fecal Rearing - 5 100 2.0  >256  4 
218 Fecal Rearing - 5 200 2.3  >256  0.19 
219 Fecal Rearing - 5 1’100 3.0  >256  0.19 
220 Fecal Fattening + 1 3’700 3.6  >256  0.125 
221 Fecal Fattening - 1 100 2.0  256  0.19 
222 Fecal Fattening + 1 200 2.3  >256  8 
223 Fecal Fattening + 1 100 2.0  256  0.125 
224 Fecal Fattening + 1 900 3.0  >256  8 
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225 Fecal Fattening + 1 15’000 4.2  256  0.125 
226 Fecal Fattening + 1 100 2.0  256  0.125 
227 Fecal Fattening + 1 100 2.0  >256  6 
228 Fecal Fattening + 1 400 2.6  192  0.19 
229 Fecal Fattening + 1 15’000 4.2  256  0.125 
230 Fecal Fattening + 2 100 2.0  >256  0.19 
231 Fecal Fattening + 2 500 2.7  256  0.19 
232 Fecal Fattening + 2 100 2.0  256  0.094 
233 Fecal Fattening + 2 7’100 3.9  >256  6 
234 Fecal Fattening + 2 100 2.0  >256  8 
235 Fecal Fattening + 2 100 2.0  256  0.125 
236 Fecal Fattening + 3 100 2.0  256  0.19 
237 Fecal Fattening - 3 200 2.3  256  0.19 
238 Fecal Fattening - 3 100 2.0  256  0.125 
239 Fecal Fattening - 3 100 2.0  256  0.19 
240 Fecal Fattening - 3 300 2.5  256  0.19 
241 Fecal Fattening - 3 200 2.3  256  0.19 
242 Fecal Fattening - 3 3’100 3.5  256  0.25 
243 Fecal Fattening - 3 200 2.3  256  0.125 
244 Fecal Fattening - 4 200 2.3  256  0.19 
245 Fecal Fattening - 4 500 2.7  256  0.25 
246 Fecal Fattening - 4 100 2.0  >256  0.19 
247 Fecal Fattening - 4 100 2.0  256  0.19 
248 Fecal Fattening - 4 600 2.8  256  0.19 
249 Fecal Fattening - 4 300 2.5  256  0.19 
250 Fecal Fattening - 4 100 2.0  256  0.125 
251 Fecal Fattening - 4 200 2.3  256  0.19 
252 Fecal Fattening - 4 2’500 3.4  256  0.19 
253 Fecal Fattening - 5 3’700 3.6  >256  0.125 
254 Fecal Fattening - 5 200 2.3  >256  0.19 
255 Dust Farrowing + 1, 2 70’000 4.8  64  0.25 
256 Wipe Farrowing - 1, 2 2’000 3.3  96  0.19 
257 Wipe Farrowing + 1, 2 200 2.3  >256  4 
258 Wipe Farrowing - 3, 4 2’000 3.3  >256  24 
259 Wipe Farrowing - 3, 4 2’000 3.3  >256  8 
260 Wipe Farrowing + 1, 2 5’350 3.7  >256  4 
261 Wipe Farrowing + 1, 2 5’900 3.8  24  0.047 
262 Wipe Farrowing - 3, 4 200 2.3  256  0.19 
263 Wipe Rearing + 3, 4 100 2.0  >256  8 
264 Wipe Fattening + 3, 4 600 2.8  >256  >32 
265 Wipe Fattening - 3, 4 200 2.3  >256  >32 
266 Wipe Fattening - 3, 4 200 2.3  256  0.19 
267 Wipe Fattening - 3, 4 1’000 3.0  >256  0.19 
268 Wipe Fattening-CL + 1, 2 400 2.6  24  0.38 
269 Wipe Fattening-CL - 1, 2 14’200 4.2  32  0.19 
270 Wipe Fattening-CL + 1, 2 5’100 3.7  >256  6 
271 Slurry Farrowing + 3, 4 200 2.3  >257  >32 
272 Slurry Farrowing + 3, 4 16’000 4.2  >257  >32 
273 Slurry Rearing + 1, 2 3’000 3.5  24  0.25 
274 Slurry Rearing + 1, 2 100 2.0  256  0.125 
275 Slurry Rearing + 1, 2 1’000 3.0  256  0.125 
276 Slurry Rearing + 3, 4 8’000 3.9  >256  0.125 
277 Slurry Fattening + 1, 2 4’000 3.6  256  0.125 
278 Slurry Fattening - 3, 4 2’000 3.3  256  0.19 




QNSE CFU/g or ml: Quinolone non-susceptible E. coli counts in colony forming units per gram feces/dust/wipe or per milliliter slurry 
QNSE log CFU/g or ml: quinolone non-susceptible E. coli counts in log10 colony forming units per gram feces/dust/wipe or per milliliter 
slurry 
MICNA : minimal inhibitory concentration of nalidixic acid in microgram per milliliter (µg/ml) 
MICCIP: minimal inhibitory concentration of ciprofloxacin in microgram per milliliter (µg/ml) 
SPS+ : connected to a sow-pool-system 
SPS-: not connected to a sow-pool-system 
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